48 results on '"Shimazaki M"'
Search Results
2. OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
- Author
-
Park, K., primary, Azuma, K., additional, Tsai, C., additional, Seto, T., additional, Nokihara, H., additional, Yang, J.C., additional, Kim, S., additional, Murakami, H., additional, Nishio, M., additional, Kiura, K., additional, Inoue, A., additional, Takeda, K., additional, Kang, J., additional, Hayashi, H., additional, Nakagawa, T., additional, Kaneko, Y., additional, Akazawa, R., additional, Shimazaki, M., additional, Morita, S., additional, Fukuoka, M., additional, and Nakagawa, K., additional
- Published
- 2017
- Full Text
- View/download PDF
3. An input-output table perspective on measuring construction productivity
- Author
-
Shimazaki, M., Liu, Chunlu, Song, Yu, Itoh, Yoshito, Shimazaki, M., Liu, Chunlu, Song, Yu, and Itoh, Yoshito
- Abstract
In the field of construction economics, input-output analysis based studies' have attracted a lot of interest from the academics and researchers. The wide efforts are to carry out analyses and comparisons of economic indicators in construction sectors across countries and years. There has been little research modelling the construction productivity using input-output tables. This research takes advantage of the input-output analysis to develop a perspective for determining the productivity of an industrial sector. The developed quantitative formulas are fully based on the economic indicators generated from an input-output table. Using the newly published OECD input-output database, historical analyses and comparisons are carried out to indicate the differences of prod uctivi ties of the construction sectors in Australia and Japan.
- Published
- 2004
4. Post-marketing Surveillance (PMS) of all Patients Treated with Irinotecan in Japan: Clinical Experience and ADR Profile of 13 935 Patients
- Author
-
Tadokoro, J.-i., primary, Kakihata, K., additional, Shimazaki, M., additional, Shiozawa, T., additional, Masatani, S., additional, Yamaguchi, F., additional, Sakata, Y., additional, Ariyoshi, Y., additional, and Fukuoka, M., additional
- Published
- 2011
- Full Text
- View/download PDF
5. Immunoelectron microscopy of carbonic anhydrase isozyme VI in human submandibular gland: comparison with isozymes I and II.
- Author
-
Ogawa, Y, primary, Hong, S S, additional, Toyosawa, S, additional, Kuwahara, H, additional, Shimazaki, M, additional, and Yagi, T, additional
- Published
- 1993
- Full Text
- View/download PDF
6. GENERAL SESSION
- Author
-
KASHIO, Nobuyuki, primary, HIGUCHI, Itsuro, additional, USUKI, Fusako, additional, NATAHARA, Keiti, additional, NAKAGAWA, Masanori, additional, OSAME, Mitsuhiro, additional, MURATA, Fusayoshi, additional, KATAOKA, Katsuko, additional, KANTANI-MATSUMOTO, Akiko, additional, SUZAKI, Etsuko, additional, KATAYAMA, Sadao, additional, KITO, Shozo, additional, KATO, Kohtaro, additional, YOKOSE, Satoshi, additional, TAJIMA, Yoshifumi, additional, Kato, Seiji, additional, KATO, Yoshiko, additional, YASUDA, Jinsuke, additional, HATSUDA, Kazuyoshi, additional, FUJIWARA, Youichiro, additional, SAWADA, Shigenari, additional, OKADA, Hiroji, additional, KAWABATA, Teruyuki, additional, OZAKI, Michitaka, additional, AWAI, Michiyasu, additional, KAWAGOE, Koh, additional, AKIYAMA, Junko, additional, KAWAHARADA, Umeko, additional, SUZUKI, Keiji, additional, NAKAJIMA, Katsuyuki, additional, KAWAI, Kenji, additional, HORI, Sadaaki, additional, OSAMURA, Yoshiyuki, additional, Kawakami, Hayato, additional, Ito, Masataka, additional, Miura, Yuki, additional, Saito, Shozo, additional, Aoyagi, Toshio, additional, Hirano, Hiroshi, additional, KAWANO, Jun-icni, additional, OINUMA, Tsutomu, additional, SUGANUMA, Tatsuo, additional, KOBAYASHI, Makio, additional, KAWAOI, Akira, additional, ASAYAMA, Kohtaro, additional, Komatsu, Toshiko, additional, KOMORI, Kaoru, additional, MIURA, Kiyokuni, additional, TAKEUCHI, Terumi, additional, SAKAI, Masao, additional, KARASAWA, Nobuyuki, additional, Konishi, Eiichi, additional, Morotomi, Naofumi, additional, Kamachi, Masahiro, additional, Urata, Yoji, additional, Ashihara, Tsukasa, additional, KOSE, Akiko, additional, ITO, Atsuko, additional, HIRATA, Midori, additional, TSUJINO, Takeshi, additional, YOSHIHARA, Chika, additional, SAITO, Naoaki, additional, TANAKA, Chikako, additional, KUBO, Hiromichi, additional, OTSUKI, Yoshinori, additional, MAGARI, Sumiko, additional, SUGIMOTO, Osamu, additional, ASADA-KUBOTA, Mari, additional, KANAMURA, Shinsuke, additional, KUMAMOTO, Tetsuzo, additional, HIROHATA, Tajimi, additional, KUNIKATA, Mayuko, additional, YAMADA, Kazuto, additional, MORI, Masahiko, additional, KUWAHARA, H., additional, SHIMAZAKI, M., additional, KADOYA, Y., additional, KOBAYASHI, A., additional, OGAWA, Y., additional, YAGI, T., additional, LEE, Masao, additional, ARAKI, Nobukazu, additional, TAKASHIMA, Yoichiro, additional, LUO, Shenqiu, additional, SAKAI, Masahiro, additional, OGAWA, Kazuo, additional, MAEDA, Toshihiro, additional, FUJIMIYA, Mineko, additional, KOJIMA, Yasuji, additional, KITAHAMA, Kunio, additional, MATSUBARA, Shigeki, additional, TAMADA, Taro, additional, SAITO, Takuma, additional, MATSUSHIMA, Hisashi, additional, TAKASAGO, Masakazu, additional, ASO, Yoshio, additional, MATSUTA, Morimasa, additional, MURAKAMI, Keiko, additional, IZUTSU, Toshihiko, additional, KAGABU, Teruo, additional, NISHIYA, Iwao, additional, MATSUTANI, Shinji, additional, YAMAMOTO, Noboru, additional, MIKI, Koji, additional, YAMADA, Shigeto, additional, KOJIMA, Hideki, additional, YOSHIDA, Masami, additional, NISHI, Syogoro, additional, NAGATSU, Ikuko, additional, WATANABE, Kazuyoshi, additional, MIYAZAKI, Makoto, additional, FUJIMURA, Masaki, additional, AIMI, Yoshinari, additional, TOOYAMA, Ikuo, additional, KIMURA, Hiroshi, additional, Miyoshi, N., additional, Hayashi, T., additional, Nakanishi, K., additional, Miyabo, S., additional, Fukuda, M., additional, MIZUKAWA, Kiminao, additional, OTSUKA, Nagayasu, additional, Mizuno, M., additional, Fujimoto, T., additional, Ogawa, K., additional, MORIYAMA, Nobuo, additional, Hara, Makoto, additional, HIGASHIHARA, Eiji, additional, MURAHASHI, Isao, additional, MURAKOSHI, Masanori, additional, INADA, Rie, additional, SUZUKI, Minoru, additional, WATANABE, Kei-i-ichi, additional, Murata, S., additional, Itoi, H., additional, Urata, Y., additional, Matsuzuka, F., additional, Tsuchihashi, Y., additional, Ashihara, T., additional, Nagahama, Shin'ichi, additional, Kadoya, Yoshinori, additional, Ohashi, Hirotugu, additional, Shimazaki, Masayoshi, additional, Ogawa, Yuzo, additional, Yagi, Toshio, additional, and NAGASE, Yasushi, additional
- Published
- 1989
- Full Text
- View/download PDF
7. GENERAL SESSION
- Author
-
SASAKI, Fumie, primary, NAKAGAWA, Shiro, additional, SUEMATSU, Chiharu, additional, HIROHATA, Tajimi, additional, SHIMIZU, Eiichi, additional, KUMAMOTO, Tetsuzo, additional, FUKAYA, Terutaka, additional, YAMAMOTO, Isao, additional, KAGEYAMA, Naoki, additional, SAITO, Takuma, additional, SUGIMURA, Kimiya, additional, MIZUTANI, Akira, additional, YOSHIKAWA, Kazuhiro, additional, IIJIMA, Koichi, additional, AKAGI, Yoshio, additional, IBATA, Yasuhiko, additional, Sano, Yutaka, additional, DABHOLKAR, A.S., additional, OGAWA, K., additional, MIZUKAWA, Kiminao, additional, SHIMIZU, Keisuke, additional, MATSUURA, Tadao, additional, AOKI, Yoshiyuki, additional, OFUJI, Tadashi, additional, OTSUKA, Nagayasu, additional, SAHASHI, Ko, additional, FUKUNAGA, Hidetoshi, additional, YAZIMA, Fumúko, additional, UONO, Masanori, additional, INOUE, Koichi, additional, NISHI, Tatsunori, additional, KANDA, Shigeto, additional, Kawaoi, Akira, additional, OKANO, Tadao, additional, AMAKAWA, TAKANORI, additional, MIYAZAKI, RYUNOSUKE, additional, SANO, Mamoru, additional, KEINO, Hiromi, additional, NISHIYAMA, Fumiaki, additional, SHIODA, Toshiro, additional, IRIMURA, Tatsuro, additional, HIRANO, Hiroshi, additional, Morimoto, N., additional, Shimizu, S., additional, Yamada, K., additional, KANEDA, Yoshimasa, additional, TAKIGUCHI, Norio, additional, MACHINAKA, Emiyo, additional, MORII, Sotokichi, additional, KAMI, Koji, additional, MITSUI, Tadao, additional, SUZUKI, Toshio, additional, YAMASHIMA, Shohei, additional, MIZUHIRA, Vinci, additional, AMEMIYA, Tsugio, additional, UENO, Satoki, additional, YAMAGUCHI, Toshiyuki, additional, HIROSE, Shunta, additional, IWASA, Zenzi, additional, HIROSE, Masaaki, additional, SHINDO, Katsuhisa, additional, RAZZAQ, A.K.A., additional, SHIMIZU, Minoru, additional, KAWASAKI, Takatoshi, additional, NAGAI, Hirotoshi, additional, MIYAMOTO, Tokuhiro, additional, SHIMAZAKI, M., additional, MITSUHASHI, T., additional, ASAI, N., additional, SASAKI, T., additional, HASEGAWA, R., additional, AOBA, T., additional, GAN, Masanobu, additional, IKEDA, Akira, additional, Akiyoshi, Masatoyo, additional, Tamura, Hideo, additional, Yano, Saburo, additional, Nakada, Hozumi, additional, Sato, Kiichi, additional, NADA, Osami, additional, HIRATA, Kazuho, additional, TAKENO, Kyoko, additional, WATANABE, Yoshinori, additional, TAKANO, Terukazu, additional, NUMANO, Fujio, additional, Kobayashi, M., additional, Takahashi, T., additional, Moriya, K., additional, Shimamoto, T., additional, Shioya, Y., additional, Fujino, H., additional, Numano, F., additional, SUZUKI, Hiroshi, additional, OHISHI, Takao, additional, WATANABE, Shaw, additional, MIKATA, Atsuo, additional, YAMADA, Masa-oki, additional, TAKEUCHI, Hisashi, additional, FUJIMORI, Ken, additional, Maruo, Naoyuki, additional, Isemura, Takuji, additional, Fukuda, Masaru, additional, Fujita, Setsuya, additional, DAIMON, Tateo, additional, UCHIDA, Kazuko, additional, Murata, F., additional, Momose, Y., additional, Nagata, T., additional, KAKUTA, Sachiko, additional, MORIMOTO, Kouhei, additional, YAMASHINA, Shohei, additional, KAMO, Shigeyoshi, additional, HATAI, Ben, additional, WATANABE, Kensuke, additional, OHISI, Takao, additional, WATAMABE, Shaw, additional, KAGEYAMA, Keizo, additional, ASO, Yoshio, additional, ONO, T., additional, YAMAMOTO, N., additional, YASUDA, K., additional, IWATSUKI, Hirohiko, additional, Shannon, W. Allen, additional, Hoshino, Yoshinobu, additional, Seligman, Arnold M., additional, SUZUKI, Takuro, additional, KIMURA, Masaru, additional, NOKUBI, Kazuto, additional, MURAKI, Takeshi, additional, KATO, Morio, additional, KIMURA, Hiroshi, additional, TOHYAMA, Masaya, additional, MAEDA, Toshihiro, additional, SHIMIZU, Nobuo, additional, SENO, Jiro, additional, OSAWA, Kotaro, additional, MAEDA, Ryuei, additional, Koide, Tsutomu, additional, Kameya, Toru, additional, Shimosato, Yukio, additional, KISHINO, Yasuo, additional, SUMI, Toshiko, additional, ABE, Muneaki, additional, AOE, Hajime, additional, TAKETA, Kazuhisa, additional, UEDA, Masatoshi, additional, KOSAKA, Kiyowo, additional, TANAKA, Akira, additional, FUKUDA, Haruo, additional, ITO, Motohiko, additional, MIYAYAMA, Haruhiko, additional, FISHMAN, William H., additional, CHIDA, Kosuke, additional, YAMAMOTO, Noboru, additional, YASUDA, Kenjiro, additional, KANAMURA, Shinsuke, additional, OGAWA, Kazuo, additional, KAKO, M., additional, TORII, M., additional, SUZUKI, H., additional, TODA, G., additional, MIYAKE, K., additional, OKAZAKI, K., additional, ODA, T., additional, Teranobu, Osamu, additional, Sumitani, Yukio, additional, Shimada, Keiichi, additional, Maeda, Masaho, additional, Sugiyama, Taketoshi, additional, KISHI, Kanji, additional, NISHIJIMA, Katsumi, additional, ISHIDA, Toshihiro, additional, NAGATSUKA, Takahito, additional, TSUNASHIMA, Masakazu, additional, SENO, Satimaru, additional, YOSHIOKA, Toshio, additional, TAKAOKA, Kunio, additional, SUGIMOTO, Akitoshi, additional, OHYUMI, Masao, additional, TAKEUCHI, Tadao, additional, Yamashita, S., additional, HISAMITSU, Shotaro, additional, TAKEUCHI, Haruaki, additional, NAGATA, Tetsuji, additional, MURATA, Fusayoshi, additional, SAKAI, Ken, additional, OKABE, Michro, additional, ETO, Komyo, additional, TAKAYA, Kenichi, additional, GOTO, Keiko, additional, AKEMATSU, Tomotoshi, additional, SHIMAZU, Hajime, additional, KANO, Yoshio, additional, KAWAKITA, Yozo, additional, SUGIHARA, Hajime, additional, BANDO, Yoshikiyo, additional, Nakanishi, Kazuo, additional, and Shima, Akihiro, additional
- Published
- 1976
- Full Text
- View/download PDF
8. Evolutionary history of anglerfishes (Teleostei: Lophiiformes): a mitogenomic perspective
- Author
-
Shimazaki Mitsuomi, Ho Hsuan-Ching, Shedlock Andrew M, Satoh Takashi P, Arnold Rachel J, Orr James W, Pietsch Theodore W, Miya Masaki, Yabe Mamoru, and Nishida Mutsumi
- Subjects
Evolution ,QH359-425 - Abstract
Abstract Background The teleost order Lophiiformes, commonly known as the anglerfishes, contains a diverse array of marine fishes, ranging from benthic shallow-water dwellers to highly modified deep-sea midwater species. They comprise 321 living species placed in 68 genera, 18 families and 5 suborders, but approximately half of the species diversity is occupied by deep-sea ceratioids distributed among 11 families. The evolutionary origins of such remarkable habitat and species diversity, however, remain elusive because of the lack of fresh material for a majority of the deep-sea ceratioids and incompleteness of the fossil record across all of the Lophiiformes. To obtain a comprehensive picture of the phylogeny and evolutionary history of the anglerfishes, we assembled whole mitochondrial genome (mitogenome) sequences from 39 lophiiforms (33 newly determined during this study) representing all five suborders and 17 of the 18 families. Sequences of 77 higher teleosts including the 39 lophiiform sequences were unambiguously aligned and subjected to phylogenetic analysis and divergence time estimation. Results Partitioned maximum likelihood analysis confidently recovered monophyly for all of the higher taxa (including the order itself) with the exception of the Thaumatichthyidae (Lasiognathus was deeply nested within the Oneirodidae). The mitogenomic trees strongly support the most basal and an apical position of the Lophioidei and a clade comprising Chaunacoidei + Ceratioidei, respectively, although alternative phylogenetic positions of the remaining two suborders (Antennarioidei and Ogcocephaloidei) with respect to the above two lineages are statistically indistinguishable. While morphology-based intra-subordinal relationships for relatively shallow, benthic dwellers (Lophioidei, Antennarioidei, Ogcocephaloidei, Chaunacoidei) are either congruent with or statistically indistinguishable from the present mitogenomic tree, those of the principally deep-sea midwater dwellers (Ceratioidei) cannot be reconciled with the molecular phylogeny. A relaxed molecular-clock Bayesian analysis of the divergence times suggests that all of the subordinal diversifications have occurred during a relatively short time period between 100 and 130 Myr ago (early to mid Cretaceous). Conclusions The mitogenomic analyses revealed previously unappreciated phylogenetic relationships among the lophiiform suborders and ceratioid familes. Although the latter relationships cannot be reconciled with the earlier hypotheses based on morphology, we found that simple exclusion of the reductive or simplified characters can alleviate some of the conflict. The acquisition of novel features, such as male dwarfism, bioluminescent lures, and unique reproductive modes allowed the deep-sea ceratioids to diversify rapidly in a largely unexploited, food-poor bathypelagic zone (200-2000 m depth) relative to the other lophiiforms occurring in shallow coastal areas.
- Published
- 2010
- Full Text
- View/download PDF
9. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)
- Author
-
Sally-Anne Vincent, Michael S. Zandi, Camilla Buckley, Giuliano Tomei, Belinda R Lennox, Ly-Mee Yu, Ksenija Yeeles, Mio Shimazaki, Francis Dowling, Eileen M. Joyce, Anne Lingford Hughes, Alasdair Coles, Peter B. Jones, Thomas Kabir, Thomas R. E. Barnes, Iona Cairns, Timothy Harrower, Rebecca Pollard, Akram A. Hosseini, Lennox B., Yeeles K., Jones P.B., Zandi M., Joyce E., Yu L.-M., Tomei G., Pollard R., Vincent S.-A., Shimazaki M., Cairns I., Dowling F., Kabir T., Barnes T.R.E., Lingford Hughes A., Hosseini A.A., Harrower T., Buckley C., Coles A., Zandi, Michael [0000-0002-9612-9401], Coles, Alasdair [0000-0003-4738-0760], and Apollo - University of Cambridge Repository
- Subjects
Male ,Time Factors ,Placebo-controlled study ,Medicine (miscellaneous) ,Research & Experimental Medicine ,DISEASE ,law.invention ,Study Protocol ,PROGNOSTIC-FACTORS ,0302 clinical medicine ,Randomized controlled trial ,Risk Factors ,law ,SCHIZOPHRENIA ,Multicenter Studies as Topic ,Pharmacology (medical) ,Infusions, Intravenou ,030212 general & internal medicine ,Infusions, Intravenous ,1102 Cardiorespiratory Medicine and Haematology ,Randomized Controlled Trials as Topic ,lcsh:R5-920 ,Positive and Negative Syndrome Scale ,Hazard ratio ,Immunoglobulins, Intravenous ,RECEPTOR ENCEPHALITIS ,Middle Aged ,3. Good health ,Treatment Outcome ,Medicine, Research & Experimental ,Female ,Rituximab ,lcsh:Medicine (General) ,Life Sciences & Biomedicine ,Human ,Antipsychotic Agents ,medicine.drug ,Adult ,Psychosis ,medicine.medical_specialty ,Time Factor ,Adolescent ,Psychotic Disorder ,Placebo ,MECHANISMS ,Young Adult ,03 medical and health sciences ,Clinical Trials, Phase II as Topic ,Double-Blind Method ,General & Internal Medicine ,Internal medicine ,medicine ,Humans ,Aged ,Science & Technology ,business.industry ,Risk Factor ,1103 Clinical Sciences ,medicine.disease ,United Kingdom ,Clinical trial ,Antipsychotic Agent ,Psychotic Disorders ,Cardiovascular System & Hematology ,Immunoglobulins, Intravenou ,business ,030217 neurology & neurosurgery - Abstract
Background Evidence is conflicting about a causal role of inflammation in psychosis and, specifically, regarding antibodies binding to neuronal membrane targets, especially N-methyl-D-aspartate receptors. NMDAR, LGI1 and GABA-A antibodies were found more prevalent in people with psychosis than in healthy controls. We aim to test whether these antibodies are pathogenic and may cause isolated psychosis. The SINAPPS2 phase IIa double-blinded randomised controlled trial will test the efficacy and safety of immunoglobulin and rituximab treatment versus placebo for patients with acute psychosis symptoms as added to psychiatric standard of care. Methods We will screen approximately 2500 adult patients with acute psychosis to identify 160 with antibody-positive psychosis without co-existing neurological disease and recruit about 80 eligible participants to the trial in the period from September 2017 to September 2021 across the UK. Eligible patients will be randomised 1:1 either to intravenous immunoglobulin (IVIG) followed by rituximab or to placebo infusions of 1% albumin followed by 0.9% sodium chloride, respectively. To detect a time-to-symptomatic-recovery hazard ratio of 0.322 with a power of 80%, 56 participants are needed to complete the trial, allowing for up to 12 participants to drop out of each group. Eligible patients will be randomised and assessed at baseline within 4 weeks of their eligibility confirmation. The treatment will start with IVIG or 1% albumin placebo infusions over 2–4 consecutive days no later than 7 days from baseline. It will continue 4–5 weeks later with a rituximab or sodium chloride placebo infusion and will end 2–3 weeks after this with another rituximab or placebo infusion. The primary outcome is the time to symptomatic recovery defined as symptomatic remission sustained for at least 6 months on the following Positive and Negative Syndrome Scale items: P1, P2, P3, N1, N4, N6, G5 and G9. Participants will be followed for 12 months from the first day of treatment or, where sustained remission begins after the first 6 months, for an additional minimum of 6 months to assess later response. Discussion The SINAPPS2 trial aims to test whether immunotherapy is efficacious and safe in psychosis associated with anti-neuronal membrane antibodies. Trial registration ISRCTN, 11177045. Registered on 2 May 2017. EudraCT, 2016-000118-31. Registered on 22 November 2016. ClinicalTrials.gov, NCT03194815. Registered on 21 June 2017. Electronic supplementary material The online version of this article (10.1186/s13063-019-3336-1) contains supplementary material, which is available to authorized users.
- Published
- 2019
- Full Text
- View/download PDF
10. Edge Modes and Nonlocal Conductance in Graphene Superlattices
- Author
-
Brown R., Walet N.R., Guinea F. and 'We have analyzed the nature of edge states in superlattices of gapped graphene on BN. We have shown that nontrivial patterns of Berry curvature are induced in the superlattice Brillouin zone, giving rise to Chern numbers that are typically nonzero, and change from subband to subband',' topological edge modes are thus generic for a Hamiltonian describing modulated fields in monolayer graphene, as is suitable for graphene on BN. The precise value of these numbers depends on details of the superlattice potential, although they are generally present provided that physically reasonable superlattice parameters are used. The existence of finite Chern numbers in the superlattice bands leads to a valley Hall effect. These results are confirmed by real space calculations for superlattice ribbons. We find dispersive bands and crossings near the corners of the Brillouin zone. Currents along the superlattice edges are degraded by short-range intervalley scattering, whereas in clean graphene samples electronic transport is limited by long range, intravalley scattering. The effect of disorder localized at the edges is suppressed by the long decay length of the states, due to the small size of the gaps. Simple estimates of the mean free path and localization length associated with edge disorder give values in the order of microns. This provides an explanation for the low resistivities found in electronic transport measurements of graphene on BN [35] (see also Ref. [17] ). We have demonstrated that the superlattice is of importance to the transport properties of graphene on a substrate such as BN, or as a means to measure the valley Hall effect. We would like to thank M. Ben Shalom, V. Fal’ko, A. Geim, and J. Walbank for useful conversations. This work was supported by funding from the European Union through the European Research Council Advanced Grant NOVGRAPHENE through Grant Agreement No. 290846, and from the European Commission under the Graphene Flagship, Contract No. CNECTICT-604391. [1] 1 M. Fujita , K. Wakabayashi , K. Nakada , and K. Kusakabe , J. Phys. Soc. Jpn. 65 , 1920 ( 1996 ). JUPSAU 0031-9015 10.1143/JPSJ.65.1920 [2] 2 K. Nakada , M. Fujita , G. Dresselhaus , and M.?S. Dresselhaus , Phys. Rev. B 54 , 17954 ( 1996 ). PRBMDO 0163-1829 10.1103/PhysRevB.54.17954 [3] 3 A.?R. Akhmerov and C.?W.?J. Beenakker , Phys. Rev. B 77 , 085423 ( 2008 ). PRBMDO 1098-0121 10.1103/PhysRevB.77.085423 [4] 4 L. Brey and H.?A. Fertig , Phys. Rev. B 73 , 235411 ( 2006 ). PRBMDO 1098-0121 10.1103/PhysRevB.73.235411 [5] 5 M.?V. Berry and R.?J. Mondragon , Proc. R. Soc. A 412 , 53 ( 1987 ). PRLAAZ 1364-5021 10.1098/rspa.1987.0080 [6] 6 N.?M.?R. Peres , F. Guinea , and A.?H. Castro Neto , Phys. Rev. B 73 , 125411 ( 2006 ). PRBMDO 1098-0121 10.1103/PhysRevB.73.125411 [7] 7 B. Wunsch , T. Stauber , F. Sols , and F. Guinea , Phys. Rev. Lett. 101 , 036803 ( 2008 ). PRLTAO 0031-9007 10.1103/PhysRevLett.101.036803 [8] 8 K. Wakabayashi , M. Fujita , H. Ajiki , and M. Sigrist , Phys. Rev. B 59 , 8271 ( 1999 ). PRBMDO 0163-1829 10.1103/PhysRevB.59.8271 [9] 9 A.?H. Castro Neto , F. Guinea , N.?M.?R. Peres , K.?S. Novoselov , and A.?K. Geim , Rev. Mod. Phys. 81 , 109 ( 2009 ). RMPHAT 0034-6861 10.1103/RevModPhys.81.109 [10] 10 V.?N. Kotov , B. Uchoa , V.?M. Pereira , F. Guinea , and A.?H. Castro Neto , Rev. Mod. Phys. 84 , 1067 ( 2012 ). RMPHAT 0034-6861 10.1103/RevModPhys.84.1067 [11] 11 C. Tao , L. Jiao , O.?V. Yazyev , Y.-C. Chen , J. Feng , X. Zhang , R.?B. Capaz , J.?M. Tour , A. Zettl , S.?G. Louie , H. Dai , and M.?F. Crommie , Nat. Phys. 7 , 616 ( 2011 ). NPAHAX 1745-2473 10.1038/nphys1991 [12] 12 M.?T. Allen , O. Shtanko , I.?C. Fulga , A. Akhmerov , K. Watanabe , T. Taniguchi , P. Jarillo-Herrero , L.?S. Levitov , and A. Yacoby , Nat. Phys. 12 , 128 ( 2016 ). NPAHAX 1745-2473 10.1038/nphys3534 [13] 13 S. Wang , L. Talirz , C.?A. Pignedoli , X. Feng , K. Müllen , R. Fasel , and P. Ruffieux , Nat. Commun. 7 , 11507 ( 2016 ). NCAOBW 2041-1723 10.1038/ncomms11507 [14] 14 E.?V. Castro , N.?M.?R. Peres , J.?M.?B. Lopes dos Santos , A.?H. Castro Neto , and F. Guinea , Phys. Rev. Lett. 100 , 026802 ( 2008 ). PRLTAO 0031-9007 10.1103/PhysRevLett.100.026802 [15] 15 D. Weckbecker , S. Shallcross , M. Fleischmann , N. Ray , S. Sharma , and O. Pankratov , Phys. Rev. B 93 , 035452 ( 2016 ). PRBMDO 2469-9950 10.1103/PhysRevB.93.035452 [16] 16 R. Bistritzer , and A.?H. MacDonald , Proc. Natl. Acad. Sci. U.S.A. 108 , 12233 ( 2011 ). PNASA6 0027-8424 10.1073/pnas.1108174108 [17] 17 J. Marmolejo-Tejada , J. García , X.-L. Chang , P.-H. and Sheng , A. Cresti , S. Roche , and B.?K. Nikolic , arXiv:1706.09361 . [18] 18 T.?T. Heikkilä and G.?E. Volovik , JETP Lett. 93 , 59 ( 2011 ). JTPLA2 0021-3640 10.1134/S002136401102007X [19] 19 T.?T. Heikkilä , N.?B. Kopnin , and G.?E. Volovik , JETP Lett. 94 , 233 ( 2011 ). JTPLA2 0021-3640 10.1134/S0021364011150045 [20] 20 M.?Z. Hasan and C.?L. Kane , Rev. Mod. Phys. 82 , 3045 ( 2010 ). RMPHAT 0034-6861 10.1103/RevModPhys.82.3045 [21] 21 X.-L. Qi and S.-C. Zhang , Rev. Mod. Phys. 83 , 1057 ( 2011 ). RMPHAT 0034-6861 10.1103/RevModPhys.83.1057 [22] 22 J. Li , I. Martin , M. Buttiker , and A.?F. Morpurgo , Nat. Phys. 7 , 38 ( 2011 ). NPAHAX 1745-2473 10.1038/nphys1822 [23] 23 H. Watanabe , Y. Hatsugai , and H. Aoki , Phys. Rev. B 82 , 241403 ( 2010 ). PRBMDO 1098-0121 10.1103/PhysRevB.82.241403 [24] 24 M. Sui , G. Chen , L. Ma , W. Shan , D. Tian , K. Watanabe , T. Taniguchi , X. Jin , W. Yao , D. Xiao , and Y. Zhang , Nat. Phys. 11 , 1027 ( 2015 ). NPAHAX 1745-2473 10.1038/nphys3485 [25] 25 Y. Shimazaki , M. Yamamoto , I.?V. Borzenets , K. Watanabe , T. Taniguchi , and S. Tarucha , Nat. Phys. 11 , 1032 ( 2015 ). NPAHAX 1745-2473 10.1038/nphys3551 [26] 26 L. Ju , Z. Shi , N. Nair , Y. Lv , C. Jin , J. Velasco Jr , C. Ojeda-Aristizabal , H.?A. Bechtel , M.?C. Martin , A. Zettl , J. Analytis , and F. Wang , Nature (London) 520 , 650 ( 2015 ). NATUAS 0028-0836 10.1038/nature14364 [27] 27 J. Li , K. Wang , K.?J. McFaul , Z. Zern , Y. Ren , K. Watanabe , T. Taniguchi , Z. Qiao , and J. Zhu , Nat. Nanotechnol. 11 , 1060 ( 2016 ). NNAABX 1748-3387 [28] 28 M.?J. Zhu , A.?V. Kretinin , M.?D. Thompson , D.?A. Bandurin , S. Hu , G.?L. Yu , J. Birkbeck , A. Mishchenko , I.?J. Vera-Marun , K. Watanabe , T. Taniguchi , M. Polini , J.?R. Prance , K.?S. Novoselov , A.?K. Geim , and M. Ben Shalom , Nat. Commun. 8 , 14552 ( 2017 ). NCAOBW 2041-1723 10.1038/ncomms14552 [29] 29 M. Yankowitz , J. Xue , D. Cormode , J.?D. Sanchez-Yamagishi , K. Watanabe , T. Taniguchi , P. Jarillo-Herrero , P. Jacquod , and B.?J. LeRoy , Nat. Phys. 8 , 382 ( 2011 ). NPAHAX 1745-2473 10.1038/nphys2272 [30] 30 L.?A. Ponomarenko , R.?V. Gorbachev , G.?L. Yu , D.?C. Elias , R. Jalil , A.?A. Patel , A. Mishchenko , A.?S. Mayorov , C.?R. Woods , J.?R. Wallbank , M. Mucha-Kruczynski , B.?A. Piot , M. Potemski , I.?V. Grigorieva , K.?S. Novoselov , F. Guinea , V.?I. Fal’ko , and A.?K. Geim , Nature (London) 497 , 594 ( 2013 ). NATUAS 0028-0836 10.1038/nature12187 [31] 31 C.?R. Dean , L. Wang , P. Maher , C. Forsythe , F. Ghahari , Y. Gao , J. Katoch , M. Ishigami , P. Moon , M. Koshino , K.?T. Taniguchi , T. Watanabe , K.?L. Shepard , J. Hone , and P. Kim , Nature (London) 497 , 598 ( 2013 ). NATUAS 0028-0836 10.1038/nature12186 [32] 32 B. Hunt , J.?D. Sanchez-Yamagishi , A.?F. Young , K. Watanabe , T. Taniguchi , P. Moon , M. Koshino , P. Jarillo-Herrero , and R.?C. Ashoori , Science 340 , 1427 ( 2013 ). SCIEAS 0036-8075 10.1126/science.1237240 [33] 33 C.?R. Woods , L. Britnell , A. Eckmann , G.?L. Yu , R.?V. Gorbachev , A. Kretinin , A.?J. Park , L.?A. Ponomarenko , M.?I. Katsnelson , Y.?N. Gornostyrev , K. Watanabe , T. Taniguchi , C. Casiraghi , A.?K. Geim , and K.?S. Novoselov , Nat. Phys. 10 , 451 ( 2014 ). NPAHAX 1745-2473 10.1038/nphys2954 [34] 34 G.?L. Yu , R.?V. Gorbachev , J.?S. Tu , A.?V. Kretinin , Y. Cao , R. Jalil , F. Withers , L.?A. Ponomarenko , B.?A. Piot , M. Potemski , D.?C. Elias , X. Chen , K. Watanabe , T. Taniguchi , I.?V. Grigorieva , K.?S. Novoselov , V.?I. Fal’ko , A.?K. Geim , and A. Mishchenko , Nat. Phys. 10 , 525 ( 2014 ). NPAHAX 1745-2473 10.1038/nphys2979 [35] 35 R.?V. Gorbachev , J.?C.?W. Song , G.?L. Yu , A.?V. Kretinin , F. Withers , Y. Cao , A. Mishchenko , I.?V. Grigorieva , K.?S. Novoselov , L.?S. Levitov , and A.?K. Geim , Science 346 , 448 ( 2014 ). SCIEAS 0036-8075 10.1126/science.1254966 [36] 36 Z. Dou , S. Morikawa , A. Cresti , S. Wang , C.?G. Smith , C. Melios , O. Kazakova , K. Watanabe , T. Taniguchi , S. Masubuchi , T. Machida , and M.?R. Connolly , arXiv:1711.08005 . [37] 37 J. Chae , S. Jung , S. Woo , H. Baek , J. Ha , Y.?J. Song , Y.-W. Son , N.?B. Zhitenev , J.?A. Stroscio , and Y. Kuk , Nano Lett. 12 , 1839 ( 2012 ). NALEFD 1530-6984 10.1021/nl2041222 [38] 38 Y.?D. Lensky , J.?C.?W. Song , P. Samutpraphoot , and L.?S. Levitov , Phys. Rev. Lett. 114 , 256601 ( 2015 ). PRLTAO 0031-9007 10.1103/PhysRevLett.114.256601 [39] 39 See Supplementary Material at http://link.aps.org/supplemental/10.1103/PhysRevLett.120.026802 for additional details of our tight-binding Hamiltonian and current distribution models, which includes Refs. [40, 41]. [40] 40 R. Kundu , Mod. Phys. Lett. B 25 , 163 ( 2011 ). MPLBET 0217-9849 10.1142/S0217984911025663 [41] 41 A.?L. Kuzemsky , Int. J. Mod. Phys. B 25 , 3071 ( 2011 ). IJPBEV 0217-9792 10.1142/S0217979211059012 [42] 42 J. Jung , E. Laksono , A.?M. DaSilva , A.?H. MacDonald , M. Mucha-Kruczy?ski , and S. Adam , Phys. Rev. B 96 , 085442 ( 2017 ). PRBMDO 2469-9950 10.1103/PhysRevB.96.085442 [43] 43 M. Kindermann , B. Uchoa , and D.?L. Miller , Phys. Rev. B 86 , 115415 ( 2012 ). PRBMDO 1098-0121 10.1103/PhysRevB.86.115415 [44] 44 J.?C.?W. Song , A.?V. Shytov , and L.?S. Levitov , Phys. Rev. Lett. 111 , 266801 ( 2013 ). PRLTAO 0031-9007 10.1103/PhysRevLett.111.266801 [45] 45 P. San-Jose , A. Gutiérrez-Rubio , M. Sturla , and F. Guinea , Phys. Rev. B 90 , 075428 ( 2014 ). PRBMDO 1098-0121 10.1103/PhysRevB.90.075428 [46] 46 J. Jung , A. Raoux , Z. Qiao , and A.?H. MacDonald , Phys. Rev. B 89 , 205414 ( 2014 ). PRBMDO 1098-0121 10.1103/PhysRevB.89.205414 [47] 47 M. Neek-Amal and F.?M. Peeters , Appl. Phys. Lett. 104 , 041909 ( 2014 ). APPLAB 0003-6951 10.1063/1.4863661 [48] 48 P. Moon and M. Koshino , Phys. Rev. B 90 , 155406 ( 2014 ). PRBMDO 1098-0121 10.1103/PhysRevB.90.155406 [49] 49 J.?R. Wallbank , A.?A. Patel , M. Mucha-Kruczy?ski , A.?K. Geim , and V.?I. Fal’ko , Phys. Rev. B 87 , 245408 ( 2013 ). PRBMDO 1098-0121 10.1103/PhysRevB.87.245408 [50] 50 T. Fukui , Y. Hatsugai , and H. Fuzuki , J. Phys. Soc. Jpn. 74 , 1674 ( 2005 ). JUPSAU 0031-9015 10.1143/JPSJ.74.1674 [51] 51 D.?A. Abanin , K.?S. Novoselov , U. Zeitler , P.?A. Lee , A.?K. Geim , and L.?S. Levitov , Phys. Rev. Lett. 98 , 196806 ( 2007 ). PRLTAO 0031-9007 10.1103/PhysRevLett.98.196806 [52] 52 N.?J.?G. Couto , D. Costanzo , S. Engels , D.-K. Ki , K. Watanabe , T. Taniguchi , C. Stampfer , F. Guinea , and A.?F. Morpurgo , Phys. Rev. X 4 , 041019 ( 2014 ). PRXHAE 2160-3308 10.1103/PhysRevX.4.041019'
- Published
- 2018
11. Monitoring sodium caseinate and whey protein isolate interaction with mild preheat treatment using ultrasound spectroscopy and confocal laser scanning microscopy.
- Author
-
Yuno-Ohta N, Hoshi Y, Shimazaki M, Ohta H, and Hori K
- Subjects
- Hot Temperature, Lactones chemistry, Spectrum Analysis methods, Gluconates chemistry, Whey Proteins chemistry, Caseins chemistry, Microscopy, Confocal
- Abstract
Ultrasound spectroscopy and confocal laser scanning microscopy (CLSM) methods were developed to visualize the interaction between sodium caseinate (SC) and whey protein isolate (WPI) with a mild preheat treatment (57°C, 10 min) followed by adding glucono-δ-lactone (GDL). Ultrasonic velocity changes during incubation at 25°C after adding GDL for four kinds of mixtures (no-treated SC plus no-treated WPI, preheated SC plus no-treated WPI, no-treated SC plus preheated WPI and preheated SC plus preheated WPI) were monitored. The results reveal that the mild preheating treatment of the proteins affected the timing of the increase in compressibility of each system. CLSM observation with individualized dyes which have different maxima of excitation and emission wavelengths, showed the preheated SC plus no-treated WPI mixture had a slightly coarse structure and the highest correlation coefficient, suggesting the highest colocalization of the SC and WPI among the four kinds of mixed-protein systems. Furthermore, the scanning electron microscopy (SEM) observation suggests that there are some differences among the gels, namely, preheated WPI leads to the formation of developed three-dimensional gel networks with filamentous structures, whereas SC promotes the formation of cluster-like crowded networks composed of more fine aggregated particles instead of developed filamentous structures. These results demonstrated that although SC is known as a heat-stable protein, pretreated SC could lead to an increase of the collaboration with WPI in the presence of GDL. This finding anticipated the possibility creating a food material with another texture using a milk-protein mixed system., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
12. Improvement of Rectal Prolapse Using an Over-the-scope Clip System.
- Author
-
Iwasa T, Adachi S, Suzuki Y, Takada E, Matsuura K, Mabuchi M, Nakamura H, Shimazaki M, Nishiwaki S, Ibuka T, Iwashita T, and Shimizu M
- Subjects
- Humans, Female, Aged, 80 and over, Surgical Instruments, Treatment Outcome, Rectal Prolapse surgery, Colonoscopy instrumentation, Colonoscopy methods
- Abstract
Rectal prolapse is typically treated surgically, and internal therapy has not been reported. We encountered a case of rectal prolapse that improved with an over-the-scope clip (OTSC) system. An 81-year-old woman complaining of anorectal pain underwent colonoscopy, and rectal prolapse was observed prior to colonoscopy. Unfortunately, rectal perforation occurred while attempting endoscopic reversal. The OTSC system was used to close the rectal perforation and subsequently improved her rectal prolapse, probably because the rectal wall was anchored to the retroperitoneum. This is the first report to show that rectal prolapse can be endoscopically improved and that an OTSC system might be a viable alternative method for managing inoperable rectal prolapse.
- Published
- 2024
- Full Text
- View/download PDF
13. Investigation of walking speed and plantar pressure after chopart amputation.
- Author
-
Ouchi K, Sato M, Kashiwabara Y, Shimazaki M, and Yabuki S
- Subjects
- Humans, Male, Aged, Artificial Limbs, Walking, Pressure, Amputation, Surgical, Foot, Walking Speed
- Abstract
Background: In foot amputation, Chopart amputation is considered to have a high risk of deformity, and can result in poor function. We experienced a case in which Chopart amputation combined with tendon transfer and tendon lengthening was performed, and the patient was eventually able to walk independently with a foot prosthesis without experiencing deformity of the foot. We investigated walking speed and plantar pressure after Chopart amputation with and without a foot prosthesis., Case: A 78-year-old man underwent Chopart amputation with tendon transfer and tendon lengthening. As a result, he was able to stand up and walk, both while bearing weight on the heel of the affected foot, but he was unable to push off the ground using that foot. When a foot prosthesis was introduced, the patient's walking speed increased from 0.6 m/s without the prosthesis to 0.8 m/s with the prosthesis, which was an increase of 33%. The plantar pressure at the stump decreased from 129.3 N/cm
2 on average without the prosthesis to 51.6 N/cm2 with the prosthesis, which was a 59% decrease. Wearing a foot prosthesis improved the patient's walking speed and decreased plantar pressure at the amputation stump.- Published
- 2024
- Full Text
- View/download PDF
14. Balloon-occlusion Retrograde Transvenous Obliteration Using Gadoteridol As an Alternative Contrast Agent in a Patient with Iodine Allergy.
- Author
-
Iwasa T, Adachi S, Oyama Y, Suzuki Y, Mabuchi M, Nakamura H, Shimazaki M, Nishiwaki S, Iwashita T, and Shimizu M
- Subjects
- Female, Humans, Aged, Contrast Media adverse effects, Treatment Outcome, Gadolinium, Esophageal and Gastric Varices, Hepatic Encephalopathy, Balloon Occlusion methods, Hypersensitivity, Heterocyclic Compounds, Organometallic Compounds
- Abstract
A 70-year-old woman with liver cirrhosis presented with gastric varices and recurrent hepatic encephalopathy. Magnetic resonance imaging (MRI) showed a splenorenal shunt, and balloon-occluded retrograde transvenous obliteration (B-RTO) was indicated but could not be performed due to iodine allergy. We then performed B-RTO using gadoteridol, an MRI contrast medium, instead of iodine contrast and successfully occluded the shunt vessel. After the procedure, hepatic encephalopathy did not recur, and the size of the gastric varices was reduced. This experience may aid in the management of iodine-allergic patients requiring interventional radiological treatment.
- Published
- 2024
- Full Text
- View/download PDF
15. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Crohn's Disease Patients Who Failed Anti-tumor Necrosis Factor-α Treatment in Japan: An Observational Study Utilizing Claims Database.
- Author
-
Shimazaki M, Matsuyama Y, and Koide D
- Subjects
- Humans, Tumor Necrosis Factor-alpha, Japan, Treatment Outcome, Necrosis chemically induced, Retrospective Studies, Ustekinumab therapeutic use, Crohn Disease drug therapy, Antibodies, Monoclonal, Humanized
- Abstract
This study aimed to investigate whether the approved sequence of vedolizumab and ustekinumab impacts the results of previous observational studies conducted in the European Union (EU), comparing the effectiveness of these drugs in Crohn's disease (CD) patients who failed anti-tumor necrosis factor-α (TNFα) treatment. We conducted this study in Japan, where the approved sequence of drugs is different from that of the EU. We extracted 256 patients diagnosed with CD, who had a history of anti-TNFα treatment and were prescribed either vedolizumab or ustekinumab, from JMDC claims database. The patients' backgrounds were adjusted by inverse probability of treatment weighting using propensity score. The primary outcome was treatment persistence. Secondary outcomes were a steroid-free period, time to hospitalization, and time to CD-related surgery. The hazard ratios (HR) for survival times were estimated using the Cox proportional hazard model. The treatment persistence (primary endpoint) was significantly longer for ustekinumab than vedolizumab (HR, 0.32; 95% confidence interval (CI), 0.15-0.72). The results of the secondary endpoints were as follows: steroid-free period (HR, 0.38; 95% CI, 0.10-1.48), time to hospitalization (HR, 1.07; 95% CI, 0.60-1.91), or time to CD-related surgery (HR, 0.33; 95% CI, 0.11-0.97). There were no outcomes indicating the superiority of vedolizumab. Our findings suggest that ustekinumab is a more effective treatment option than vedolizumab for CD patients who failed to anti-TNFα treatment, and this finding remains consistent across both Japan and the EU.
- Published
- 2024
- Full Text
- View/download PDF
16. Invasive Group G Streptococcal Infection Complicated by Posterior Reversible Encephalopathy Syndrome: A Case Report.
- Author
-
Nakamura H, Adachi S, Uno Y, Mabuchi M, Shimazaki M, Nishiwaki S, and Shimizu M
- Subjects
- Male, Humans, Aged, 80 and over, Magnetic Resonance Imaging methods, Systemic Inflammatory Response Syndrome, Posterior Leukoencephalopathy Syndrome, Duodenal Ulcer complications, Disseminated Intravascular Coagulation complications, Streptococcal Infections complications, Streptococcal Infections diagnosis
- Abstract
BACKGROUND Group G streptococcus (GGS) infection is reported to have invasive pathogenicity similar to that of group A streptococcus (GAS) infection, causing a strong systemic inflammatory response with bacteremia and various complications. Herein, we report a case of posterior reversible encephalopathy syndrome (PRES) as a rare complication of a GGS infection. CASE REPORT An 89-year-old Japanese man presented to our hospital with gastrointestinal bleeding and shoulder pain. Close examination revealed a refractory duodenal ulcer (DU) with disseminated intravascular coagulation and soft tissue infection of the right arm, which was found to be caused by GGS. A hemorrhagic tendency due to disseminated intravascular coagulation made it difficult to achieve hemostasis, leading to repeated blood transfusions. Although remission of both the DU and infection was achieved with treatment, impairment of swallowing function and vision subsequently appeared. Magnetic resonance imaging revealed hyperintense lesions with elevated apparent diffusion coefficient (ADC) values on T2-weighted imaging (T2WI), fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI). The patient was diagnosed with PRES, which did not improve even after discharge on day 118. CONCLUSIONS GGS infection developed with refractory duodenal ulcer bleeding, resulting in PRES with irreversible sequelae. The occurrence of PRES, which may be a rare complication of GGS infection, should be considered when central nervous system manifestations are observed in case of invasive streptococcal infection with a systemic inflammatory response.
- Published
- 2023
- Full Text
- View/download PDF
17. Drainage of Afferent Limb Obstruction via the Trans-gastric-bile Duct Formed after Endoscopic Ultrasound-guided Hepaticogastrostomy in a Patient with Pancreatic Cancer.
- Author
-
Mabuchi M, Adachi S, Uno Y, Nakamura H, Shimazaki M, Nishiwaki S, Kumazawa I, Iwashita T, and Shimizu M
- Subjects
- Humans, Male, Middle Aged, Bile Ducts pathology, Drainage, Endosonography adverse effects, Ultrasonography, Interventional, Pancreatic Neoplasms, Pancreatic Neoplasms complications, Pancreatic Neoplasms surgery
- Abstract
A 63-year-old man with advanced pancreatic cancer and pyloric obstruction underwent surgical gastrojejunostomy. Malignant biliary obstruction appeared eight months after surgery and was managed with endoscopic ultrasound (EUS)-guided hepaticogastrostomy (HGS). Subsequently, afferent limb obstruction caused by cancer invasion occurred. Although an intestinal metal stent could not be placed, a biliary metal stent was deployed via the HGS route, which successfully decompressed the afferent limb; the abdominal symptoms subsequently disappeared. In future similar cases, decompression of the dilated intestine through the HGS and biliary stent might be a viable treatment option.
- Published
- 2023
- Full Text
- View/download PDF
18. NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism.
- Author
-
Okada N, Ueki C, Shimazaki M, Tsujimoto G, Kohno S, Muranaka H, Yoshikawa K, and Takahashi C
- Subjects
- Humans, Animals, Mice, Lipid Metabolism genetics, Cell Line, Tumor, Prognosis, Lipogenesis, CCAAT-Binding Factor metabolism, Triple Negative Breast Neoplasms metabolism
- Abstract
Two splicing variants exist in NFYA that exhibit high expression in many human tumour types. The balance in their expression correlates with prognosis in breast cancer, but functional differences remain unclear. Here, we demonstrate that NFYAv1, a long-form variant, upregulates the transcription of essential lipogenic enzymes ACACA and FASN to enhance the malignant behavior of triple-negative breast cancer (TNBC). Loss of the NFYAv1-lipogenesis axis strongly suppresses malignant behavior in vitro and in vivo, indicating that the NFYAv1-lipogenesis axis is essential for TNBC malignant behavior and that the axis might be a potential therapeutic target for TNBC. Furthermore, mice deficient in lipogenic enzymes, such as Acly, Acaca, and Fasn, exhibit embryonic lethality; however, Nfyav1-deficient mice exhibited no apparent developmental abnormalities. Our results indicate that the NFYAv1-lipogenesis axis has tumour-promoting effects and that NFYAv1 may be a safe therapeutic target for TNBC., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
19. Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models.
- Author
-
Nakayama A, Nagashima T, Nishizono Y, Kuramoto K, Mori K, Homboh K, Yuri M, and Shimazaki M
- Subjects
- A549 Cells, Animals, Antineoplastic Combined Chemotherapy Protocols pharmacology, Cell Line, Tumor, HCT116 Cells, Humans, Male, Mice, Piperazines pharmacology, Pyridines pharmacology, Pyrimidines pharmacology, Random Allocation, Small Molecule Libraries chemistry, Small Molecule Libraries pharmacology, Xenograft Model Antitumor Assays, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Drug Resistance, Neoplasm drug effects, Mutation, Piperazines administration & dosage, Proto-Oncogene Proteins p21(ras) genetics, Pyridines administration & dosage, Pyrimidines administration & dosage, Small Molecule Libraries administration & dosage
- Abstract
Background: KRAS is one of the most frequently mutated oncogenes in various cancers, and several novel KRAS G12C direct inhibitors are now in clinical trials. Here, we characterised the anti-tumour efficacy of ASP2453, a novel KRAS G12C inhibitor, in preclinical models of KRAS G12C-mutated cancer., Methods: We evaluated the in vitro and in vivo activity of ASP2453, alone or in combination with targeted agents and immune checkpoint inhibitors, in KRAS G12C-mutated cancer cells and xenograft models. We also assessed pharmacological differences between ASP2453 and AMG 510, another KRAS G12C inhibitor, using an SPR assay, washout experiments and an AMG 510-resistant xenograft model., Results: ASP2453 potently and selectively inhibited KRAS G12C-mediated growth, KRAS activation and downstream signalling in vitro and in vivo, and improved the anti-tumour effects of targeted agents and immune checkpoint inhibitors. Further, ASP2453 had more rapid binding kinetics to KRAS G12C protein and showed more potent inhibitory effects on KRAS activation and cell proliferation after washout than AMG 510. ASP2453 also induced tumour regression in an AMG 510-resistant xenograft model., Conclusions: ASP2453 is a potential therapeutic agent for KRAS G12C-mutated cancer. ASP2453 showed efficacy in AMG 510-resistant tumours, even among compounds with the same mode of action., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
20. Virtual clinical trial simulations for a novel KRAS G12C inhibitor (ASP2453) in non-small cell lung cancer.
- Author
-
Sayama H, Marcantonio D, Nagashima T, Shimazaki M, Minematsu T, Apgar JF, Burke JM, Wille L, Nagasaka Y, and Kirouac DC
- Subjects
- Animals, Carcinoma, Non-Small-Cell Lung genetics, Computer Simulation, Humans, Lung Neoplasms genetics, Mice, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Mutation, Network Pharmacology, Organic Chemicals administration & dosage, Organic Chemicals pharmacology, Phosphorylation, Xenograft Model Antitumor Assays, Antineoplastic Agents administration & dosage, Antineoplastic Agents pharmacology, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms drug therapy, Models, Biological, Proto-Oncogene Proteins p21(ras) antagonists & inhibitors
- Abstract
KRAS is a small GTPase family protein that relays extracellular growth signals to cell nucleus. KRAS
G12C mutations lead to constitutive proliferation signaling and are prevalent across human cancers. ASP2453 is a novel, highly potent, and selective inhibitor of KRASG12C . Although preclinical data suggested impressive efficacy, it remains unclear whether ASP2453 will show more favorable clinical response compared to more advanced competitors, such as AMG 510. Here, we developed a quantitative systems pharmacology (QSP) model linking KRAS signaling to tumor growth in patients with non-small cell lung cancer. The model was parameterized using in vitro ERK1/2 phosphorylation and in vivo xenograft data for ASP2453. Publicly disclosed clinical data for AMG 510 were used to generate a virtual population, and tumor size changes in response to ASP2453 and AMG 510 were simulated. The QSP model predicted ASP2453 exhibits greater clinical response than AMG 510, supporting potential differentiation and critical thinking for clinical trials., (© 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.)- Published
- 2021
- Full Text
- View/download PDF
21. Dietary Cystine Ameliorates Defects in Spermatogenesis via Testosterone Production Induced by Protein Deficiency and Darkness in Rats.
- Author
-
Obata F, Yu G, Ohta H, Susuki N, Shimazaki M, Nishimura S, and Hanai M
- Subjects
- Animals, Dietary Proteins administration & dosage, Dietary Proteins pharmacology, Male, Organ Size drug effects, Rats, Testis drug effects, Cystine administration & dosage, Cystine pharmacology, Darkness adverse effects, Diet, Protein-Restricted adverse effects, Spermatogenesis drug effects, Testosterone metabolism
- Abstract
Nutrition and light-dark cycle influence rat testicular development. With 9% casein diet (low protein diet) under normal 12 h-12 h lighting cycles (9P), juvenile rat testes undergo normal growth. On the other hand, a low protein diet with constant darkness (D9P) results in a growth arrest of rat testes. Supplementation of cystine to the low protein diet under constant darkness (D9PC) had a tendency to increase testes weight, suggesting an improvement in growth suppression. Whether the growth suppression of testes in D9P is associated with suppression of spermatogenesis has not yet been shown. We aimed to determine the effect of a low protein diet and constant darkness with or without dietary cystine in testes using a histological technique. In the histological assessment, D9P testes showed a decreased number of seminiferous tubules with elongated spermatids, indicating a functional testicular defect in this group. However, cystine supplementation resulted in enhanced spermatogenesis versus control animals (D9PC vs. D9P) implying the importance of cystine to testicular development in this condition. Furthermore, serum testosterone concentration was increased in D9PC suggesting contribution of testosterone to ameliorate spermatogenesis. From these results, we conclude that cystine supplementation to a low protein diet under constant darkness promoted an increase in testosterone which in turn benefitted spermatogenesis.
- Published
- 2020
- Full Text
- View/download PDF
22. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
- Author
-
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu LM, Tomei G, Pollard R, Vincent SA, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckley C, and Coles A
- Subjects
- Adolescent, Adult, Aged, Antipsychotic Agents adverse effects, Clinical Trials, Phase II as Topic, Double-Blind Method, Female, Humans, Immunoglobulins, Intravenous adverse effects, Infusions, Intravenous, Male, Middle Aged, Multicenter Studies as Topic, Psychotic Disorders diagnosis, Psychotic Disorders immunology, Psychotic Disorders psychology, Randomized Controlled Trials as Topic, Risk Factors, Rituximab adverse effects, Time Factors, Treatment Outcome, United Kingdom, Young Adult, Antipsychotic Agents administration & dosage, Immunoglobulins, Intravenous administration & dosage, Psychotic Disorders drug therapy, Rituximab administration & dosage
- Abstract
Background: Evidence is conflicting about a causal role of inflammation in psychosis and, specifically, regarding antibodies binding to neuronal membrane targets, especially N-methyl-D-aspartate receptors. NMDAR, LGI1 and GABA-A antibodies were found more prevalent in people with psychosis than in healthy controls. We aim to test whether these antibodies are pathogenic and may cause isolated psychosis. The SINAPPS2 phase IIa double-blinded randomised controlled trial will test the efficacy and safety of immunoglobulin and rituximab treatment versus placebo for patients with acute psychosis symptoms as added to psychiatric standard of care., Methods: We will screen approximately 2500 adult patients with acute psychosis to identify 160 with antibody-positive psychosis without co-existing neurological disease and recruit about 80 eligible participants to the trial in the period from September 2017 to September 2021 across the UK. Eligible patients will be randomised 1:1 either to intravenous immunoglobulin (IVIG) followed by rituximab or to placebo infusions of 1% albumin followed by 0.9% sodium chloride, respectively. To detect a time-to-symptomatic-recovery hazard ratio of 0.322 with a power of 80%, 56 participants are needed to complete the trial, allowing for up to 12 participants to drop out of each group. Eligible patients will be randomised and assessed at baseline within 4 weeks of their eligibility confirmation. The treatment will start with IVIG or 1% albumin placebo infusions over 2-4 consecutive days no later than 7 days from baseline. It will continue 4-5 weeks later with a rituximab or sodium chloride placebo infusion and will end 2-3 weeks after this with another rituximab or placebo infusion. The primary outcome is the time to symptomatic recovery defined as symptomatic remission sustained for at least 6 months on the following Positive and Negative Syndrome Scale items: P1, P2, P3, N1, N4, N6, G5 and G9. Participants will be followed for 12 months from the first day of treatment or, where sustained remission begins after the first 6 months, for an additional minimum of 6 months to assess later response., Discussion: The SINAPPS2 trial aims to test whether immunotherapy is efficacious and safe in psychosis associated with anti-neuronal membrane antibodies., Trial Registration: ISRCTN, 11177045. Registered on 2 May 2017. EudraCT, 2016-000118-31. Registered on 22 November 2016. ClinicalTrials.gov, NCT03194815. Registered on 21 June 2017.
- Published
- 2019
- Full Text
- View/download PDF
23. Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.
- Author
-
Murakami H, Nokihara H, Hayashi H, Seto T, Park K, Azuma K, Tsai CM, Yang JC, Nishio M, Kim SW, Kiura K, Inoue A, Takeda K, Kang JH, Nakagawa T, Takeda K, Akazawa R, Kaneko Y, Shimazaki M, Morita S, Fukuoka M, and Nakagawa K
- Subjects
- Adult, Aged, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung mortality, ErbB Receptors genetics, Female, Humans, Lung Neoplasms genetics, Lung Neoplasms mortality, Male, Middle Aged, Piperazines adverse effects, Piperazines pharmacokinetics, Piperidines adverse effects, Piperidines pharmacokinetics, Pyrazines adverse effects, Pyrazines pharmacokinetics, Pyrrolidines adverse effects, Pyrrolidines pharmacokinetics, Antineoplastic Agents therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, ErbB Receptors antagonists & inhibitors, Lung Neoplasms drug therapy, Mutation, Piperazines therapeutic use, Piperidines therapeutic use, Protein Kinase Inhibitors therapeutic use, Pyrazines therapeutic use, Pyrrolidines therapeutic use
- Abstract
Epidermal growth factor receptor (EGFR)-activating mutations confer sensitivity to tyrosine kinase inhibitor (TKI) treatment for non-small-cell lung cancer (NSCLC). ASP8273 is a highly specific, irreversible, once-daily, oral, EGFR TKI that inhibits both activating and resistance mutations. This ASP8273 dose-escalation/dose-expansion study (NCT02192697) was undertaken in two phases. In phase I, Japanese patients (aged ≥20 years) with NSCLC previously treated with ≥1 EGFR TKI received escalating ASP8273 doses (25-600 mg) to assess safety/tolerability and to determine the maximum tolerated dose (MTD) and/or the recommended phase II dose (RP2D) by the Bayesian Continual Reassessment Method. In phase II, adult patients with T790M-positive NSCLC in Japan, Korea, and Taiwan received ASP8273 at RP2D to further assess safety/tolerability and determine antitumor activity, which was evaluated according to Simon's two-stage design (threshold response = 30%, expected response = 50%, α = 0.05, β = 0.1). Overall, 121 (n = 45 [33W/12M] phase I, n = 76 [48W/28M]) phase 2) patients received ≥1 dose of ASP8273. In phase I, RP2D and MTD were established as 300 and 400 mg, respectively. As 27 of the 63 patients treated with ASP8273 300 mg achieved a clinical response, ASP8273 was determined to have antitumor activity. The overall response rate at week 24 in all patients was 42% (n = 32/76; 95% confidence interval, 30.9-54.0). Median duration of progression-free survival was 8.1 months (95% confidence interval, 5.6, upper bound not reached). The most commonly reported treatment-related adverse event in phase II was diarrhea (57%, n = 43/76). ASP8273 300 mg was generally well tolerated and showed antitumor activity in Asian patients with both EGFR-activating and T790M mutations., (© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2018
- Full Text
- View/download PDF
24. Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers.
- Author
-
Usuda K, Iwai S, Funasaki A, Sekimura A, Motono N, Ueda Y, Shimazaki M, and Uramoto H
- Subjects
- Adenocarcinoma surgery, Adult, Aged, Aged, 80 and over, Capillaries metabolism, Capillaries pathology, Carcinoma, Small Cell surgery, Carcinoma, Squamous Cell surgery, Female, Humans, Immunohistochemistry, Lung Neoplasms surgery, Male, Middle Aged, Neovascularization, Pathologic metabolism, Prognosis, Survival Rate, Actins metabolism, Adenocarcinoma blood supply, Carcinoma, Small Cell blood supply, Carcinoma, Squamous Cell blood supply, Lung Neoplasms blood supply, Neovascularization, Pathologic diagnosis, Platelet Endothelial Cell Adhesion Molecule-1 metabolism, Vascular Endothelial Growth Factor A metabolism
- Abstract
Background/aim: One of the most important factors concerning cancer growth is angiogenesis. The purpose of this study was to clarify the relationship of maturation of tumor vessels and prognosis of lung cancer., Materials and Methods: Immunohistochemical stainings of 125 lung cancers for VEGF, CD31 and α-smooth muscle actin (αSMA) were scored by multiplying the intensity and the frequency from 0 to 12., Results: Adenocarcinomas showed significantly higher staining scores of both VEGF and αSMA than squamous cell carcinomas did. In 42 cases of high CD31 score, five-year survival rate (87%) of patients with lung cancer showing mature tumor vessels was significantly better than that (69%) of patients with immature tumor vessels., Conclusion: Not the number of tumor vessels but their maturation may be a prognostic factor of patients with lung cancer. VEGF may not only stimulate proliferation of endothelial cells but also their maturation in differentiated lung cancers., (Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
25. Intraarticularly-Injected Mesenchymal Stem Cells Stimulate Anti-Inflammatory Molecules and Inhibit Pain Related Protein and Chondrolytic Enzymes in a Monoiodoacetate-Induced Rat Arthritis Model.
- Author
-
Ichiseki T, Shimazaki M, Ueda Y, Ueda S, Tsuchiya M, Souma D, Kaneuji A, and Kawahara N
- Subjects
- ADAMTS5 Protein genetics, ADAMTS5 Protein metabolism, Animals, Calcitonin Gene-Related Peptide genetics, Calcitonin Gene-Related Peptide metabolism, Cartilage, Articular metabolism, Cell Adhesion Molecules genetics, Cell Adhesion Molecules metabolism, Cells, Cultured, Disease Models, Animal, Injections, Intra-Articular, Iodoacetic Acid toxicity, Male, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells metabolism, Microscopy, Fluorescence, Osteoarthritis chemically induced, Osteoarthritis therapy, Pain pathology, Pain prevention & control, Rats, Rats, Sprague-Dawley, Spinal Cord Dorsal Horn metabolism, Spinal Cord Dorsal Horn pathology, Mesenchymal Stem Cell Transplantation, Osteoarthritis pathology
- Abstract
Persistent inflammation is well known to promote the progression of arthropathy. mesenchymal stem cells (MSCs) have been shown to possess anti-inflammatory properties and tissue differentiation potency. Although the experience so far with the intraarticular administration of mesenchymal stem cell (MSC) to induce cartilage regeneration has been disappointing, MSC implantation is now being attempted using various surgical techniques. Meanwhile, prevention of osteoarthritis (OA) progression and pain control remain important components of the treatment of early-stage OA. We prepared a shoulder arthritis model by injecting monoiodoacetate (MIA) into a rat shoulder, and then investigated the intraarticular administration of MSC from the aspects of the cartilage protective effect associated with their anti-inflammatory property and inhibitory effect on central sensitization of pain. When MIA was administered in this rat shoulder arthritis model, anti-Calcitonin Gene Related Peptide (CGRP) was expressed in the joint and C5 spinal dorsal horn. Moreover, expression of A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5), a marker of joint cartilage injury, was similarly elevated following MIA administration. When MSC were injected intraarticularly after MIA, the expression of CGRP in the spinal dorsal horn was significantly deceased, indicating suppression of the central sensitization of pain. The expression of ADAMTS 5 in joint cartilage was also significantly inhibited by MSC administration. In contrast, a significant increase in the expression of TNF-α stimulated gene/protein 6 (TSG-6), an anti-inflammatory and cartilage protective factor shown to be produced and secreted by MSC intraarticularly, was found to extend to the cartilage tissue following MSC administration. In this way, the intraarticular injection of MSC inhibited the central sensitization of pain and increased the expression of the anti-inflammatory and cartilage protective factor TSG-6. As the least invasive conservative strategies possible are desirable in the actual clinical setting, the intraarticular administration of MSC, which appears to be effective for the treatment of pain and cartilage protection in early-stage arthritis, may achieve these aims., Competing Interests: The authors have declared no conflict of interest.
- Published
- 2018
- Full Text
- View/download PDF
26. Mitochondrial stress and redox failure in steroid-associated osteonecrosis.
- Author
-
Tsuchiya M, Ichiseki T, Ueda S, Ueda Y, Shimazaki M, Kaneuji A, and Kawahara N
- Subjects
- Animals, Antioxidants metabolism, Catalase metabolism, Disease Models, Animal, Gene Expression Regulation, Enzymologic, Humans, Methylprednisolone adverse effects, Mitochondria drug effects, Mitochondria enzymology, Osteonecrosis chemically induced, Osteonecrosis pathology, Oxidation-Reduction drug effects, Rabbits, Superoxide Dismutase metabolism, Catalase genetics, Osteonecrosis enzymology, Steroids adverse effects, Superoxide Dismutase genetics
- Abstract
The purpose of the role of antioxidant enzymes and mitochondria in the developmental mechanism of steroid-associated osteonecrosis in the femur. In the present study Japanese white rabbits (mean weight 3.5kg) were injected into the gluteus with methylprednisolone (MP) 20mg/kg, and killed after 3 days (MP3 group), 5 days (MP5 group), and 14 days (MP14 group) (n=3 each). As a Control group (C group) Japanese white rabbits not administered MP were used. In experiment 1, the expression of the antioxidant enzymes Superoxide dismutade (SOD) and catalase was compared in liver, kidney, heart, humerus, and femur in C group, and the presence/absence of mitochondria transcription factor A (TFAM) expression was determined by Western blotting (WB) and used to evaluate the number of mitochondria and their function. In experiment 2, the presence/absence of necrosis was determined by immunohistochemistry, while changes in the expression of SOD, catalase, and TFAM in the femur after steroid administration were determined by Western blotting (WB). In experiment 1, intense expression of all of SOD, catalase, and TFAM was found in the liver, kidney, and heart as compared to the humerus and femur. In experiment 2, the expression of all of SOD, catalase, and TFAM in MP3 and MP5 groups was decreased on WB as compared with C group, while in MP14 group a tendency to improvement was seen. Accordingly, steroid-associated mitochondrial injury and redox failure are concluded to be important elements implicated in the pathogenesis of osteonecrosis., Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
- Published
- 2018
- Full Text
- View/download PDF
27. Improved in-cell structure determination of proteins at near-physiological concentration.
- Author
-
Ikeya T, Hanashima T, Hosoya S, Shimazaki M, Ikeda S, Mishima M, Güntert P, and Ito Y
- Subjects
- Bacterial Proteins genetics, Bacterial Proteins metabolism, Bayes Theorem, Cloning, Molecular, Escherichia coli genetics, Escherichia coli metabolism, Gene Expression, Models, Molecular, Plasmids chemistry, Plasmids metabolism, Protein Conformation, alpha-Helical, Protein Conformation, beta-Strand, Protein Interaction Domains and Motifs, Receptors, IgG genetics, Receptors, IgG metabolism, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins metabolism, Streptococcus genetics, Streptococcus metabolism, Thermodynamics, Thermus thermophilus genetics, Thermus thermophilus metabolism, Bacterial Proteins chemistry, Nuclear Magnetic Resonance, Biomolecular methods, Receptors, IgG chemistry
- Abstract
Investigating three-dimensional (3D) structures of proteins in living cells by in-cell nuclear magnetic resonance (NMR) spectroscopy opens an avenue towards understanding the structural basis of their functions and physical properties under physiological conditions inside cells. In-cell NMR provides data at atomic resolution non-invasively, and has been used to detect protein-protein interactions, thermodynamics of protein stability, the behavior of intrinsically disordered proteins, etc. in cells. However, so far only a single de novo 3D protein structure could be determined based on data derived only from in-cell NMR. Here we introduce methods that enable in-cell NMR protein structure determination for a larger number of proteins at concentrations that approach physiological ones. The new methods comprise (1) advances in the processing of non-uniformly sampled NMR data, which reduces the measurement time for the intrinsically short-lived in-cell NMR samples, (2) automatic chemical shift assignment for obtaining an optimal resonance assignment, and (3) structure refinement with Bayesian inference, which makes it possible to calculate accurate 3D protein structures from sparse data sets of conformational restraints. As an example application we determined the structure of the B1 domain of protein G at about 250 μM concentration in living E. coli cells.
- Published
- 2016
- Full Text
- View/download PDF
28. Persistent Infection of Drug-resistant Influenza A Virus during Chemotherapy for Malignant Lymphoma.
- Author
-
Kawakami T, Hirabayashi Y, Kawakami F, Isobe R, Kaneko N, Mimura Y, Ito T, Furuta K, Shimazaki M, Nakazawa H, and Kitano K
- Subjects
- Acids, Carbocyclic, Aged, 80 and over, Cyclopentanes therapeutic use, Drug Resistance, Viral, Guanidines therapeutic use, Humans, Male, Mutation, Neuraminidase genetics, Oseltamivir therapeutic use, Antiviral Agents therapeutic use, Influenza A Virus, H3N2 Subtype, Influenza, Human virology, Lymphoma drug therapy, Neuraminidase antagonists & inhibitors
- Abstract
We herein report the case of an 80-year-old man with malignant lymphoma who became persistently infected with influenza A virus. Although he was repeatedly treated with NA inhibitors, such as oseltamivir or peramivir, nasal cavity swab tests for influenza A antigen continued to be positive for more than 2 months. Virological analyses revealed that he was infected with the NA inhibitor-resistant A (H3N2) virus possessing an R292K substitution in the NA protein. These findings suggest that a drug-resistant influenza virus strain might selectively survive antiviral therapy in elderly patients with refractory malignant lymphoma undergoing multiple chemotherapies.
- Published
- 2016
- Full Text
- View/download PDF
29. PARAFAC Decomposition for Ultrasonic Wave Sensing of Fiber Bragg Grating Sensors: Procedure and Evaluation.
- Author
-
Zheng R, Nakano K, Ohashi R, Okabe Y, Shimazaki M, Nakamura H, and Wu Q
- Abstract
Ultrasonic wave-sensing technology has been applied for the health monitoring of composite structures, using normal fiber Bragg grating (FBG) sensors with a high-speed wavelength interrogation system of arrayed waveguide grating (AWG) filters; however, researchers are required to average thousands of repeated measurements to distinguish significant signals. To resolve this bottleneck problem, this study established a signal-processing strategy that improves the signal-to-noise ratio for the one-time measured signal of ultrasonic waves, by application of parallel factor analysis (PARAFAC) technology that produces unique multiway decomposition without additional orthogonal or independent constraints. Through bandpass processing of the AWG filter and complex wavelet transforms, ultrasonic wave signals are preprocessed as time, phase, and frequency profiles, and then decomposed into a series of conceptual three-way atoms by PARAFAC. While an ultrasonic wave results in a Bragg wavelength shift, antiphase fluctuations can be observed at two adjacent AWG ports. Thereby, concentrating on antiphase features among the three-way atoms, a fitting atom can be chosen and then restored to three-way profiles as a final result. An experimental study has revealed that the final result is consistent with the conventional 1024-data averaging signal, and relative error evaluation has indicated that the signal-to-noise ratio of ultrasonic waves can be significantly improved.
- Published
- 2015
- Full Text
- View/download PDF
30. The Effects of Percutaneous Endoscopic Gastrostomy on Quality of Life in Patients With Dementia.
- Author
-
Suzuki Y, Urashima M, Izumi M, Ito Y, Uchida N, Okada S, Ono H, Orimo S, Kohri T, Shigoka H, Shintani S, Tanaka Y, Yoshida A, Ijima M, Ito T, Endo T, Okano H, Maruyama M, Iwase T, Kikuchi T, Kudo M, Takahashi M, Goshi S, Mikami T, Yamashita S, Akiyama K, Ogawa T, Ogawa T, Ono S, Onozawa S, Kobayashi J, Matsumoto M, Matsumoto T, Jomoto K, Mizuhara A, Nishiguchi Y, Nishiwaki S, Aoki M, Ishizuka I, Kura T, Murakami M, Murakami A, Ohta T, Onishi K, Nakahori M, Tsuji T, Tahara K, Tanaka I, Kitagawa K, Shimazaki M, Fujiki T, Kusakabe T, Iiri T, Kitahara S, Horiuchi A, Suenaga H, Washizawa N, and Suzuki M
- Abstract
Background: To examine the effects of percutaneous endoscopic gastrostomy (PEG) on quality of life (QOL) in patients with dementia., Methods: We retrospectively included 53 Japanese community and tertiary hospitals to investigate the relationship between the newly developed PEG and consecutive dementia patients with swallowing difficulty between Jan 1st 2006 and Dec 31st 2008. We set improvements in 1) the level of independent living, 2) pneumonia, 3) peroral intake as outcome measures of QOL and explored the factors associated with these improvements., Results: Till October 31st 2010, 1,353 patients with Alzheimer's dementia (33.1%), vascular dementia (61.7%), dementia with Lewy body disease (2.0%), Pick disease (0.6%) and others were followed-up for a median of 847 days (mean 805 ± 542 days). A total of 509 deaths were observed (mortality 59%) in full-followed patients. After multivariate adjustments, improvement in the level of independent living was observed in milder dementia, or those who can live independently with someone, compared with advanced dementia, characterized by those who need care by someone: Odds Ratio (OR), 3.90, 95% confidence interval (95%CI), 1.59 - 9.39, P = 0.003. Similarly, improvement of peroral intake was noticed in milder dementia: OR, 2.69, 95%CI, 1.17 - 6.17, P = 0.02. Such significant associations were not observed in improvement of pneumonia., Conclusions: These results suggest that improvement of QOL after PEG insertion may be expected more in milder dementia than in advanced dementia.
- Published
- 2012
- Full Text
- View/download PDF
31. Post-marketing surveillance (PMS) of all patients treated with irinotecan in Japan: clinical experience and ADR profile of 13,935 patients.
- Author
-
Tadokoro J, Kakihata K, Shimazaki M, Shiozawa T, Masatani S, Yamaguchi F, Sakata Y, Ariyoshi Y, and Fukuoka M
- Subjects
- Adult, Aged, Antineoplastic Agents, Phytogenic administration & dosage, Camptothecin administration & dosage, Camptothecin adverse effects, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Small Cell drug therapy, Colorectal Neoplasms drug therapy, Diarrhea chemically induced, Drug Administration Schedule, Female, Genital Neoplasms, Female drug therapy, Glucuronosyltransferase genetics, Humans, Incidence, Infusions, Intravenous, Irinotecan, Japan, Leukopenia chemically induced, Lung Neoplasms drug therapy, Male, Middle Aged, Patient Selection, Polymorphism, Genetic, Risk Assessment, Risk Factors, Surveys and Questionnaires, Thrombocytopenia chemically induced, Antineoplastic Agents, Phytogenic adverse effects, Camptothecin analogs & derivatives, Neoplasms drug therapy, Product Surveillance, Postmarketing
- Abstract
Objective: The actual condition of drug utilization and the adverse drug reactions profile of irinotecan hydrochloride hydrate (irinotecan), an antitumor drug, were examined on the basis of all the case survey results from April 1995 to January 2000., Methods: Drug utilization and the adverse drug reactions profile of irinotecan were figured out by checking of the patient conditions at the start of therapy and monitoring during on-therapy period in this survey., Results: Among the 13 935 patients investigated, 32% had non-small cell lung cancer, 16% had colorectal cancer, 15% had ovarian cancer and 14% had small cell lung cancer, all principal cancers in which irinotecan was domestically approved for use. Most frequent regimens of each cancer were concomitant use with cisplatin for non-small cell lung cancer and small cell lung cancer (38 and 46%, respectively), concomitant use with cisplatin or mitomycin for ovarian cancer (each 30%) and irinotecan alone for colorectal cancer (51%). The major (grade 3 or more) adverse drug reactions were myelosuppressions such as leukopenia (23.8 and 38.3% for lone and concomitant use, respectively) thrombocytopenia (6.5 and 14.3%) and gastrointestinal tract disorders such as diarrhea (10.2 and 10.0%)., Conclusions: It was reconfirmed that the incidences of serious leukopenia, thrombocytopenia and diarrhea were high among the patients with contraindication or careful administration of its use prescribed in the drug package insert. Therefore, for proper use of irinotecan, it is important to discriminate the patient on the basis of risk status.
- Published
- 2011
- Full Text
- View/download PDF
32. Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing.
- Author
-
Nishiyama T, Kii I, Kashima TG, Kikuchi Y, Ohazama A, Shimazaki M, Fukayama M, and Kudo A
- Subjects
- Animals, Basement Membrane metabolism, Blotting, Western, Cell Adhesion Molecules genetics, Cell Line, Epidermal Cells, Epidermis metabolism, Fibronectins metabolism, Hair Follicle cytology, Hair Follicle metabolism, Humans, Immunohistochemistry, Immunoprecipitation, In Situ Hybridization, Laminin genetics, Laminin metabolism, Mice, NF-kappa B genetics, NF-kappa B metabolism, Phosphorylation, Protein Binding, Reverse Transcriptase Polymerase Chain Reaction, Skin injuries, Wound Healing genetics, Cell Adhesion Molecules metabolism, Skin cytology, Skin metabolism, Wound Healing physiology
- Abstract
Background: Matricellular proteins, including periostin, are important for tissue regeneration., Methods and Findings: Presently we investigated the function of periostin in cutaneous wound healing by using periostin-deficient ⁻/⁻ mice. Periostin mRNA was expressed in both the epidermis and hair follicles, and periostin protein was located at the basement membrane in the hair follicles together with fibronectin and laminin γ2. Periostin was associated with laminin γ2, and this association enhanced the proteolytic cleavage of the laminin γ2 long form to produce its short form. To address the role of periostin in wound healing, we employed a wound healing model using WT and periostin⁻/⁻ mice and the scratch wound assay in vitro. We found that the wound closure was delayed in the periostin⁻/⁻ mice coupled with a delay in re-epithelialization and with reduced proliferation of keratinocytes. Furthermore, keratinocyte proliferation was enhanced in periostin-overexpressing HaCaT cells along with up-regulation of phosphorylated NF-κB., Conclusion: These results indicate that periostin was essential for keratinocyte proliferation for re-epithelialization during cutaneous wound healing.
- Published
- 2011
- Full Text
- View/download PDF
33. Pink-colored grape berry is the result of short insertion in intron of color regulatory gene.
- Author
-
Shimazaki M, Fujita K, Kobayashi H, and Suzuki S
- Subjects
- Anthocyanins metabolism, Fruit metabolism, Gene Expression Regulation, Plant, Genomics, Nucleic Acid Conformation, Plant Epidermis metabolism, RNA, Messenger chemistry, RNA, Messenger genetics, Vitis metabolism, Fruit genetics, Genes, Plant genetics, Introns genetics, Pigmentation genetics, Vitis genetics
- Abstract
We report here that pink grape berries were obtained by a short insertion in the intron of the MybA1 gene, a gene that regulates grape berry color. Genetic variation was detected among the MybA1 genes from grapes cultivated worldwide. PCR analysis of the MybA1 gene demonstrated that the size of the MybA1 gene in the red allele differs among grapes. Oriental V. vinifera bearing pink berries has the longest MybA1 gene among grapes, whereas the shortest MybA1 gene was detected in occidental V. vinifera grapes. The nucleotide sequences of the MybA1 genes demonstrated that oriental V. vinifera has two additional gene fragments (44 bp and 111 bp) in the promoter region of the MybA1 gene in the red allele and another 33 bp fragment in the second intron of the MybA1 gene in the red allele. The short insertion in the intron decreased the transcription activity in the model system and retained MybA1 transcripts with unspliced intron in the total RNA. From the experiments using deletion mutants of the 33 bp short insertion, 16 bp of the 3' end in the insertion is a key structure for a defect in splicing of MybA1 transcripts. Thus, a weakly colored grape berry might be a result of the short insertion in the intron of a color regulatory gene. This is new evidence concerning the molecular mechanism of the fate of grape berry color. These findings are expected to contribute to the further understanding of the color variation in grape berries, which is correlated with the evolutional events occurring in the MybA1 gene of grapes.
- Published
- 2011
- Full Text
- View/download PDF
34. An N-methyl-D-aspartate receptor agonist facilitates sleep-independent synaptic plasticity associated with working memory capacity enhancement.
- Author
-
Kuriyama K, Honma M, Shimazaki M, Horie M, Yoshiike T, Koyama S, and Kim Y
- Subjects
- Adult, Circadian Rhythm physiology, Female, Humans, Male, Neuronal Plasticity drug effects, Neuronal Plasticity physiology, Nootropic Agents pharmacology, Psychomotor Performance drug effects, Psychomotor Performance physiology, Sleep drug effects, Sleep physiology, Wakefulness physiology, Young Adult, Cycloserine pharmacology, Memory, Short-Term drug effects, Memory, Short-Term physiology, Receptors, N-Methyl-D-Aspartate agonists
- Abstract
Working memory (WM) capacity improvement is impacted by sleep, and possibly by N-methyl-D-aspartate (NMDA) agonists such as D-cycloserine (DCS), which also affects procedural skill performance. However, the mechanisms behind these relationships are not well understood. In order to investigate the neural basis underlying relationships between WM skill learning and sleep, DCS, and both sleep and DCS together, we evaluated training-retest performances in the n-back task among healthy subjects who were given either a placebo or DCS before the task training, and then followed task training sessions either with wakefulness or sleep. DCS facilitated WM capacity enhancement only occurring after a period of wakefulness, rather than sleep, indicating that WM capacity enhancement is affected by a cellular heterogeneity in synaptic plasticity between time spent awake and time spent asleep. These findings may contribute to development, anti-aging processes, and rehabilitation of higher cognition.
- Published
- 2011
- Full Text
- View/download PDF
35. Survival of geriatric patients after percutaneous endoscopic gastrostomy in Japan.
- Author
-
Suzuki Y, Tamez S, Murakami A, Taira A, Mizuhara A, Horiuchi A, Mihara C, Ako E, Muramatsu H, Okano H, Suenaga H, Jomoto K, Kobayashi J, Takifuji K, Akiyama K, Tahara K, Onishi K, Shimazaki M, Matsumoto M, Ijima M, Murakami M, Nakahori M, Kudo M, Maruyama M, Takahashi M, Washizawa N, Onozawa S, Goshi S, Yamashita S, Ono S, Imazato S, Nishiwaki S, Kitahara S, Endo T, Iiri T, Nagahama T, Hikichi T, Mikami T, Yamamoto T, Ogawa T, Ogawa T, Ohta T, Matsumoto T, Kura T, Kikuchi T, Iwase T, Tsuji T, Nishiguchi Y, and Urashima M
- Subjects
- Age Factors, Aged, Aged, 80 and over, Albuminuria, Blood Urea Nitrogen, C-Reactive Protein metabolism, Cohort Studies, Deglutition Disorders diagnosis, Female, Humans, Japan, Male, Prognosis, Retrospective Studies, Sex Factors, Survival Rate, Deglutition Disorders mortality, Deglutition Disorders surgery, Endoscopy, Gastrointestinal, Gastrostomy
- Abstract
Aim: To examine the long term survival of geriatric patients treated with percutaneous endoscopic gastrostomy (PEG) in Japan., Methods: We retrospectively included 46 Japanese community and tertiary hospitals to investigate 931 consecutive geriatric patients (≥ 65 years old) with swallowing difficulty and newly performed PEG between Jan 1st 2005 and Dec 31st 2008. We set death as an outcome and explored the associations among patient's characteristics at PEG using log-rank tests and Cox proportional hazard models., Results: Nine hundred and thirty one patients were followed up for a median of 468 d. A total of 502 deaths were observed (mortality 53%). However, 99%, 95%, 88%, 75% and 66% of 931 patients survived more than 7, 30, 60 d, a half year and one year, respectively. In addition, 50% and 25% of the patients survived 753 and 1647 d, respectively. Eight deaths were considered as PEG-related, and were associated with lower serum albumin levels (P = 0.002). On the other hand, among 28 surviving patients (6.5%), PEG was removed. In a multivariate hazard model, older age [hazard ratio (HR), 1.02; 95% confidence interval (CI), 1.00-1.03; P = 0.009], higher C-reactive protein (HR, 1.04; 95% CI: 1.01-1.07; P = 0.005), and higher blood urea nitrogen (HR, 1.01; 95% CI: 1.00-1.02; P = 0.003) were significant poor prognostic factors, whereas higher albumin (HR, 0.67; 95% CI: 0.52-0.85; P = 0.001), female gender (HR, 0.60; 95% CI: 0.48-0.75; P < 0.001) and no previous history of ischemic heart disease (HR, 0.69; 95% CI: 0.54-0.88, P = 0.003) were markedly better prognostic factors., Conclusion: These results suggest that more than half of geriatric patients with PEG may survive longer than 2 years. The analysis elucidated prognostic factors.
- Published
- 2010
- Full Text
- View/download PDF
36. Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells.
- Author
-
Tanabe H, Takayama I, Nishiyama T, Shimazaki M, Kii I, Li M, Amizuka N, Katsube K, and Kudo A
- Subjects
- Animals, Cell Adhesion Molecules deficiency, Cell Adhesion Molecules genetics, Cell Line, Cell Membrane metabolism, Mice, Molar metabolism, Molecular Weight, Protein Binding, Protein Precursors chemistry, Protein Structure, Tertiary, Receptor, Notch1 chemistry, Repetitive Sequences, Amino Acid, Signal Transduction, bcl-X Protein genetics, bcl-X Protein metabolism, Cell Adhesion Molecules metabolism, Gene Expression Regulation, Molar cytology, Protein Precursors metabolism, Receptor, Notch1 metabolism, Stress, Mechanical
- Abstract
Background: Matricellular proteins, including periostin, modulate cell-matrix interactions and cell functions by acting outside of cells., Methods and Findings: In this study, however, we reported that periostin physically associates with the Notch1 precursor at its EGF repeats in the inside of cells. Moreover, by using the periodontal ligament of molar from periostin-deficient adult mice (Pn-/- molar PDL), which is a constitutively mechanically stressed tissue, we found that periostin maintained the site-1 cleaved 120-kDa transmembrane domain of Notch1 (N1) level without regulating Notch1 mRNA expression. N1 maintenance in vitro was also observed under such a stress condition as heat and H(2)O(2) treatment in periostin overexpressed cells. Furthermore, we found that the expression of a downstream effector of Notch signaling, Bcl-xL was decreased in the Pn-/- molar PDL, and in the molar movement, cell death was enhanced in the pressure side of Pn-/- molar PDL., Conclusion: These results suggest the possibility that periostin inhibits cell death through up-regulation of Bcl-xL expression by maintaining the Notch1 protein level under the stress condition, which is caused by its physical association with the Notch1 precursor.
- Published
- 2010
- Full Text
- View/download PDF
37. Evaluation of renal microcirculation by contrast-enhanced ultrasound with Sonazoid as a contrast agent.
- Author
-
Tsuruoka K, Yasuda T, Koitabashi K, Yazawa M, Shimazaki M, Sakurada T, Shirai S, Shibagaki Y, Kimura K, and Tsujimoto F
- Subjects
- Adult, Aged, Aged, 80 and over, Chronic Disease, Female, Humans, Image Enhancement, Kidney Cortex blood supply, Kidney Cortex diagnostic imaging, Kidney Diseases complications, Kidney Medulla blood supply, Kidney Medulla diagnostic imaging, Male, Middle Aged, Ultrasonography, Doppler, Young Adult, Contrast Media, Ferric Compounds, Iron, Kidney Diseases diagnostic imaging, Kidney Diseases physiopathology, Microcirculation physiology, Oxides, Renal Circulation physiology
- Abstract
Chronic kidney disease (CKD) is a major and serious risk factor for cardiovascular disease (CVD). Continuous hypoxia due to hypoperfusion in peritubular capillaries is one of the factors aggravating CKD, but evaluation of perfusion in this region is difficult using clinically available imaging methods. Since the second-generation ultrasound contrast agent Sonazoid has a stable shell, it enables visualization of the renal vasculature for a long period of time. We therefore evaluated changes in contrast-enhanced ultrasound (CEUS) imaging with Sonazoid in CKD patients.Sonazoid was used in 85 CKD patients and 5 control subjects, and images were recorded for 10 minutes. Time-intensity curves were generated from the images of 62 time points in both cortex and medulla.In control samples, contrast enhancement spread from the hilar portion to the periphery along the direction of arterial flow, and renal cortex and medulla were then enhanced in sequence. Enhancement was maximal soon after, then gradually decreased, but was still visible at 600 seconds. In CKD patients, renal contrast enhancement was attenuated in both cortex and medulla. On time-intensity curves, the attenuation of enhancement was composed of delayed rising, reduction of peak, and acceleration of decay in both cortex and medulla with progression of renal dysfunction. No side effects of the contrast agent were observed in any subjects.The attenuation of renal contrast enhancement observed in CKD patients appears to reflect disturbance of perfusion in peritubular capillaries. CEUS with Sonazoid is a useful and safe means of visualizing the renal microvasculature.
- Published
- 2010
- Full Text
- View/download PDF
38. Evolutionary history of anglerfishes (Teleostei: Lophiiformes): a mitogenomic perspective.
- Author
-
Miya M, Pietsch TW, Orr JW, Arnold RJ, Satoh TP, Shedlock AM, Ho HC, Shimazaki M, Yabe M, and Nishida M
- Subjects
- Animals, Fishes physiology, Phylogeny, Biological Evolution, Fishes classification, Fishes genetics, Genome, Mitochondrial
- Abstract
Background: The teleost order Lophiiformes, commonly known as the anglerfishes, contains a diverse array of marine fishes, ranging from benthic shallow-water dwellers to highly modified deep-sea midwater species. They comprise 321 living species placed in 68 genera, 18 families and 5 suborders, but approximately half of the species diversity is occupied by deep-sea ceratioids distributed among 11 families. The evolutionary origins of such remarkable habitat and species diversity, however, remain elusive because of the lack of fresh material for a majority of the deep-sea ceratioids and incompleteness of the fossil record across all of the Lophiiformes. To obtain a comprehensive picture of the phylogeny and evolutionary history of the anglerfishes, we assembled whole mitochondrial genome (mitogenome) sequences from 39 lophiiforms (33 newly determined during this study) representing all five suborders and 17 of the 18 families. Sequences of 77 higher teleosts including the 39 lophiiform sequences were unambiguously aligned and subjected to phylogenetic analysis and divergence time estimation., Results: Partitioned maximum likelihood analysis confidently recovered monophyly for all of the higher taxa (including the order itself) with the exception of the Thaumatichthyidae (Lasiognathus was deeply nested within the Oneirodidae). The mitogenomic trees strongly support the most basal and an apical position of the Lophioidei and a clade comprising Chaunacoidei + Ceratioidei, respectively, although alternative phylogenetic positions of the remaining two suborders (Antennarioidei and Ogcocephaloidei) with respect to the above two lineages are statistically indistinguishable. While morphology-based intra-subordinal relationships for relatively shallow, benthic dwellers (Lophioidei, Antennarioidei, Ogcocephaloidei, Chaunacoidei) are either congruent with or statistically indistinguishable from the present mitogenomic tree, those of the principally deep-sea midwater dwellers (Ceratioidei) cannot be reconciled with the molecular phylogeny. A relaxed molecular-clock Bayesian analysis of the divergence times suggests that all of the subordinal diversifications have occurred during a relatively short time period between 100 and 130 Myr ago (early to mid Cretaceous)., Conclusions: The mitogenomic analyses revealed previously unappreciated phylogenetic relationships among the lophiiform suborders and ceratioid familes. Although the latter relationships cannot be reconciled with the earlier hypotheses based on morphology, we found that simple exclusion of the reductive or simplified characters can alleviate some of the conflict. The acquisition of novel features, such as male dwarfism, bioluminescent lures, and unique reproductive modes allowed the deep-sea ceratioids to diversify rapidly in a largely unexploited, food-poor bathypelagic zone (200-2000 m depth) relative to the other lophiiforms occurring in shallow coastal areas.
- Published
- 2010
- Full Text
- View/download PDF
39. The sky blue method as a screening test to detect misplacement of percutaneous endoscopic gastrostomy tube at exchange.
- Author
-
Suzuki Y, Urashima M, Yoshida H, Iwase T, Kura T, Imazato S, Kudo M, Ohta T, Mizuhara A, Tamamori Y, Muramatsu H, Nishiguchi Y, Nishiyama Y, Takahashi M, Nishiwaki S, Matsumoto M, Goshi S, Sakamoto S, Uchida N, Ijima M, Ogawa T, Shimazaki M, Takei S, Kimura C, Yamashita S, Endo T, Nakahori M, Itoh A, Kusakabe T, Ishizuka I, Iiri T, Fukasawa S, Arimoto Y, Kajitani N, Ishida K, Onishi K, Taira A, Kobayashi M, Itano Y, and Kobuke T
- Subjects
- Aged, Aged, 80 and over, Endoscopy, Gastrointestinal, Female, Humans, Male, Middle Aged, Prospective Studies, Indigo Carmine, Intubation, Gastrointestinal methods
- Abstract
Background: During tube exchange for percutaneous endoscopic gastrostomy (PEG), a misplaced tube can cause peritonitis and death. Thus, endoscopic or radiologic observation is required at tube exchange to make sure the tube is placed correctly. However, these procedures cost extensive time and money to perform in all patients at the time of tube exchange. Therefore, we developed the "sky blue method" as a screening test to detect misplacement of the PEG tube during tube exchange., Methods: First, sky blue solution consisting of indigocarmine diluted with saline was injected into the gastric space via the old PEG tube just before the tube exchange. Next, the tube was exchanged using a standard method. Then, we checked whether the sky blue solution could be collected through the new tube or not. Finally, we confirmed correct placement of the tube by endoscopic or radiologic observation for all patients., Results: A total of 961 patients were enrolled. Each tube exchange took 1 to 3 minutes, and there were no adverse effects. Four patients experienced a misplaced tube, all of which were detectable with the sky blue method. Diagnostic parameters of the sky blue method were as follows: sensitivity, 94% (95%CI: 92-95%); specificity, 100% (95%CI: 40-100%); positive predictive value, 100% (95%CI: 100-100%); negative predictive value, 6% (95%CI: 2-16%)., Conclusion: These results suggest that the number of endoscopic or radiologic observations to confirm correct replacement of the PEG tube may be reduced to one fifteenth using the sky blue method.
- Published
- 2009
- Full Text
- View/download PDF
40. Clinical Performance of a Salivary Amylase Activity Monitor During Hemodialysis Treatment.
- Author
-
Shimazaki M, Matsuki T, Yamauchi K, Iwata M, Takahashi H, Sakamoto K, Ohata J, Nakamura Y, and Okazaki Y
- Abstract
The hemodialysis procedure is thought to be a physical stressor in the majority of hemodialyzed patients. Previous studies suggest that elevated salivary amylase level may correlate with increased plasma norepinephrine level under psychological and physical stress conditions. In this study, we investigated biological stress reactivity during hemodialysis treatment using salivary amylase activity as a biomarker. Seven patients (male/female = 5/2, age: 67.7+/-5.9 years) who had been receiving regular 4 h hemodialysis were recruited. Salivary amylase activity was measured using a portable analyzer every hour during the hemodialysis session. Salivary amylase activity was shown to be relatively stable and constant throughout hemodialysis, whereas there were significant changes in systolic blood pressure and pulse rate associated with blood volume reduction. Our results show that hemodialysis treatment per se dose not affect salivary amylase activity.
- Published
- 2008
- Full Text
- View/download PDF
41. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon.
- Author
-
Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo A, and Fukayama M
- Subjects
- Adenocarcinoma pathology, Adenoma pathology, Animals, Cell Adhesion Molecules genetics, Cell Line, Tumor, Cell Proliferation, Cells, Cultured, Coculture Techniques, Collagen Type I, Colon pathology, Colonic Neoplasms pathology, Gels, Humans, Immunohistochemistry, In Situ Hybridization, Intestinal Mucosa metabolism, Intestinal Mucosa pathology, Lung cytology, Mice, Mice, Inbred ICR, Microscopy, Immunoelectron, Reverse Transcriptase Polymerase Chain Reaction, Adenocarcinoma metabolism, Adenoma metabolism, Cell Adhesion Molecules biosynthesis, Colon metabolism, Colonic Neoplasms metabolism, Fibroblasts metabolism
- Abstract
Periostin is a unique extracellular matrix protein, deposition of which is enhanced by mechanical stress and the tissue repair process. Its significance in normal and neoplastic colon has not been fully clarified yet. Using immunohistochemistry and immunoelectron microscopy with a highly specific monoclonal antibody, periostin deposition was observed in close proximity to pericryptal fibroblasts of colonic crypts. The pericryptal pattern of periostin deposition was decreased in adenoma and adenocarcinoma, preceding the decrease of the number of pericryptal fibroblasts. Periostin immunoreactivity appeared again at the invasive front of the carcinoma and increased along the appearance of cancer-associated fibroblasts. ISH showed periostin signals in cancer-associated fibroblasts but not in cancer cells. Ki-67-positive epithelial cells were significantly decreased in the colonic crypts of periostin-/- mice (approximately 0.6-fold) compared with periostin+/+ mice. In three-dimensional co-culture within type I collagen gel, both colony size and number of human colon cancer cell line HCT116 cells were significantly larger ( approximately 1.5-fold) when cultured with fibroblasts derived from periostin+/+ mice or periostin-transfected NIH3T3 cells than with those from periostin-/- mice or periostin-non-producing NIH3T3 cells, respectively. Periostin is secreted by pericryptal and cancer-associated fibroblasts in the colon, both of which support the growth of epithelial components.
- Published
- 2008
- Full Text
- View/download PDF
42. Identification of novel genes involved in the synergistic antitumor effect of caffeine in osteosarcoma cells using cDNA macroarray.
- Author
-
Ii S, Ueda Y, Shimazaki M, Katsuta S, Takazawa K, Kanazawa Y, Tomita K, and Tsuchiya H
- Subjects
- Antineoplastic Agents pharmacology, Cell Line, Tumor, Cisplatin pharmacology, Drug Synergism, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Genes, p53, Humans, Oligonucleotide Array Sequence Analysis, Caffeine pharmacology, Osteosarcoma genetics
- Abstract
Background: Caffeine enhances the cytocidal effects of DNA-damaging agents. This study investigated genes involved in the synergistic effect of caffeine on osteosarcoma cells using gene-profiling analysis., Materials and Methods: Sensitivity to cisplatin and the synergistic effect of caffeine were evaluated in five osteosarcoma cell lines with different p53 gene status. Gene expression profiles were analyzed using cDNA macroarray and verified by real-time RT-PCR., Results: The cell lines were grouped into three types with different cytotoxic patterns. Comparison of profiling data from these groups identified twelve novel genes associated with the synergistic effect of caffeine. Real-time RT-PCR analyses verified up-regulation of two apoptosis-enhancing genes and down-regulation of two interferon-inducible genes related to the synergy of caffeine., Conclusion: These findings provide new insights into the molecular mechanisms of the synergistic effect of caffeine related to p53 gene status in osteosarcoma, providing candidates for an assay of responsiveness to caffeine-potentiated chemotherapy for osteosarcoma.
- Published
- 2008
43. Periostin is essential for cardiac healing after acute myocardial infarction.
- Author
-
Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, and Kudo A
- Subjects
- Animals, Cell Adhesion Molecules deficiency, Cell Adhesion Molecules genetics, Cicatrix metabolism, Collagen metabolism, Fibroblasts metabolism, Focal Adhesion Kinase 1 metabolism, Heart Ventricles metabolism, Humans, Male, Mice, Mice, Knockout, RNA, Messenger metabolism, Transforming Growth Factor beta metabolism, Cell Adhesion Molecules metabolism, Myocardial Infarction metabolism, Wound Healing
- Abstract
Acute myocardial infarction (AMI) is a common and lethal heart disease, and the recruitment of fibroblastic cells to the infarct region is essential for the cardiac healing process. Although stiffness of the extracellular matrix in the infarct myocardium is associated with cardiac healing, the molecular mechanism of cardiac healing is not fully understood. We show that periostin, which is a matricellular protein, is important for the cardiac healing process after AMI. The expression of periostin protein was abundant in the infarct border of human and mouse hearts with AMI. We generated periostin(-/-) mice and found no morphologically abnormal cardiomyocyte phenotypes; however, after AMI, cardiac healing was impaired in these mice, resulting in cardiac rupture as a consequence of reduced myocardial stiffness caused by a reduced number of alpha smooth muscle actin-positive cells, impaired collagen fibril formation, and decreased phosphorylation of FAK. These phenotypes were rescued by gene transfer of a spliced form of periostin. Moreover, the inhibition of FAK or alphav-integrin, which blocked the periostin-promoted cell migration, revealed that alphav-integrin, FAK, and Akt are involved in periostin signaling. Our novel findings show the effects of periostin on recruitment of activated fibroblasts through FAK-integrin signaling and on their collagen fibril formation specific to healing after AMI.
- Published
- 2008
- Full Text
- View/download PDF
44. Chronic pulmonary artery occlusion increases alveolar fluid clearance in rats.
- Author
-
Wang Z, Xu J, Ma G, Sagawa M, Shimazaki M, Ueda Y, and Sakuma T
- Subjects
- Adrenergic beta-Agonists pharmacology, Animals, Ligation, Male, Propranolol pharmacology, Pulmonary Alveoli drug effects, Pulmonary Artery surgery, Rats, Rats, Sprague-Dawley, Terbutaline pharmacology, Time Factors, Extravascular Lung Water physiology, Lung Diseases physiopathology, Pulmonary Alveoli physiopathology, Pulmonary Artery physiopathology
- Abstract
Objective: We had observed that pulmonary artery ligation for 14 days did not induce lung infiltration in a patient who had undergone a lobectomy for lung cancer. Our hypothesis was that long-term pulmonary artery ligation decreased lung water volume and/or increased alveolar fluid clearance. We determined the mechanism responsible for lung water balance in rats with chronic pulmonary artery occlusion for 14 days., Methods: Sprague-Dawley rats (n = 45) were used. Through a left thoracotomy, the left pulmonary artery was ligated for 14 days. Then, we measured lung water volume, alveolar fluid clearance, the effects of beta-adrenergic agonist and antagonist, mRNA expression, and protein expression in the lungs., Results: Chronic left pulmonary artery occlusion increased both lung water volume and alveolar fluid clearance in the left lungs, but not in the right lungs with pulmonary perfusion. Neither a beta-agonist nor a beta-antagonist changed the increase in alveolar fluid clearance. Real-time polymerase chain reaction revealed an increase in alpha1-Na,K-ATPase mRNA and a decrease of beta2-adrenoreceptor mRNA, but no change in beta1-Na,K-ATPase mRNA and alpha-, beta-, gamma-epithelial sodium channel mRNA, in the left lung without pulmonary perfusion. Western blot analysis revealed an increase in alpha1-Na,K-ATPase subunit, but no change in beta1-Na,K-ATPase subunit., Conclusion: Chronic pulmonary artery occlusion increases alveolar fluid clearance via alpha1-Na,K-ATPase overexpression in rats.
- Published
- 2007
- Full Text
- View/download PDF
45. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
- Author
-
Abe T, Uchita K, Orita H, Kamimura M, Oda M, Hasegawa H, Kobata H, Fukunishi M, Shimazaki M, Abe T, Akizawa T, and Ahmad S
- Subjects
- Adsorption, Adult, Aged, Amyloidosis blood, Equipment Design, Female, Humans, Male, Middle Aged, Treatment Outcome, Amyloidosis etiology, Amyloidosis therapy, Blood Component Removal instrumentation, Blood Component Removal methods, Renal Dialysis adverse effects, beta 2-Microglobulin metabolism
- Abstract
Background: beta2-microglobulin (beta2-m) is considered a major pathogenic factor in dialysis-related amyloidosis (DRA), often seen in long-term dialysis patients. No effective therapy for this severely debilitating disease is currently available. Lixelle, an adsorption column, has been developed for the elimination of beta2-m; the efficacy of this column has been evaluated in this study., Methods: Seventeen hemodialysis patients with DRA were first treated with high-flux dialysis for a minimum of 1 year. This was followed by 1-year treatment with Lixelle column connected in series to the high-flux dialyzer. Treatments were used three times a week for both phases of this study. During the study period, beta2-m, pinch strength, motor terminal latency, and activities of daily living were evaluated., Results: After 1-year treatment with high-flux dialysis the beta2-m level remained unchanged; however, after 1-year treatment with the addition of the Lixelle column, beta2-m level decreased significantly from 34.5 +/- 8.4 mg/L to 28.8 +/- 7.3 mg/L (P < 0.05). After 1 year of Lixelle column use, the pinch strength increased from 6.8 +/- 4.7 pounds to 9.1 +/- 5.5 pounds (P < 0.01), and the median motor terminal latency was significantly reduced from 5.1 +/- 1.0 mseconds to 4.5 +/- 1.1 mseconds. A significant improvement was also observed in the activities of daily living score of the upper extremities., Conclusion: These results suggest that the addition of Lixelle to the high-flux dialyzer is associated with a significant clinical improvement in DRA patients.
- Published
- 2003
- Full Text
- View/download PDF
46. Morphological studies on proliferation and desquamation of the alveolar lining epithelium in carrageenan-induced experimental pneumonia.
- Author
-
Mitsuhashi T, Shimazaki M, Sugino S, Takeda T, and Inariba H
- Subjects
- Animals, Cell Division, Epithelium pathology, Kinetics, Macrophages pathology, Male, Microscopy, Electron, Models, Biological, Neutrophils pathology, Pneumonia chemically induced, Rabbits, Carrageenan, Pneumonia pathology, Pulmonary Alveoli pathology
- Abstract
An experimental model of carrageenan-induced pneumonia in rabbits was used to study the proliferation and desquamation of alveolar lining epithelium, light and electron microscopically. Observation at 5 hr after intrapulmonary injection of 0.5% lambda carrageenan solution revealed epithelial cell (predominantly type 1 pneumocyte) injury, exposing the basement membrane of the alveolar wall, and that at 40 hr demonstrated an appearance of many large pneumocytes among the alveolar lining epithelium as a reparative reaction. This proliferative response of immature type 2 pneumocytes reached to the maximum in 60 and 72 hr followed by an intense desquamative response of the excessive alveolar epithelium in 5 and 6 days. The sloughed off epithelial cells were demonstrated as cell sheets or as clusters of epithelial cells. Inflammatory infiltrates in alveolar and interstitial spaces consisted of neutrophils and monocytes (or macrophages) at early stages, and mononuclear cells or macrophages at latter stages. Observation in 2nd and 3rd week showed accumulation of macrophages with many osmiophilic lamellar bodies in the alveolar spaces. The alveolar wall lining epithelium was still cuboidal or elliptical in shape in some alveoli and membranous in the others. Thickened alveolar septa at this stage were also noted. Thus this animal model appears to be a valuable tool for further understanding of the events leading to proliferation and desquamation of the alveolar lining epithelium.
- Published
- 1983
- Full Text
- View/download PDF
47. Giant to small emphysematous bullae induced by Sephadex beads and carrageenan.
- Author
-
Mitsuhashi T, Shimazaki M, Chanoki Y, Kuwahara H, Masuda H, and Sakai T
- Subjects
- Animals, Lung drug effects, Lung pathology, Male, Microspheres, Pulmonary Emphysema pathology, Rabbits, Carrageenan toxicity, Dextrans, Pulmonary Emphysema etiology
- Abstract
The effects of disturbances of the pulmonary circulation on the formation of pulmonary emphysematous bullae in rabbits were studied with the use of changes in the parenchyma of lungs insulted by both pulmonary embolization with Sephadex beads and carrageenan-induced pneumonia. Rabbits given one of the larger doses of Sephadex and then carrageenan in solution had giant bullous lesions in the lobe treated with those agents 2 months later. More animals had bullous lesions in the groups given the larger doses of Sephadex than in groups given the smallest dose or none. In animals killed after 2 weeks, bullous lesions were found, whereas there were none in those killed after 1 week. These results suggest that the size and number of bullous lesions forming in the treated lobes are associated with the dose of Sephadex. Giant and small bullous lesions are varieties of the same disorder, and there seems to be a latent period for development.
- Published
- 1986
48. 47,+(9q-) in unrelated three children with plasma growth hormone deficiency.
- Author
-
Fujita H, Shimazaki M, Takeuchi T, Hayakawa Y, and Oura T
- Subjects
- Child, Child, Preschool, Dermatoglyphics, Dwarfism, Pituitary genetics, Female, Growth, Growth Hormone metabolism, Humans, Infant, Male, Phenotype, Pituitary Function Tests, Chromosomes, Human, 6-12 and X, Growth Hormone deficiency, Trisomy
- Abstract
Marker chromosomes carried by unrelated 3 cases were identified as a part of No. 9 chromosome through the analysis of the chromatid fine structure after trypsin-giemsa treatment. They showed characteristic features of that 9p trisomic syndrome which were described by Rethoré et al. (1973). In addition to those features, some clinical and laboratory findings on growth hormon deficiency were disclosed in this report.
- Published
- 1976
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.